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Resumen
En esta memoria se obtienen y analizan algunos modelos matematicos de remod-
elacion y reparacion osea. Para ello, y tras un primer captulo introductorio en el
que se presentan resultados preliminares para los estudios posteriores, se aborda en
el Captulo 2 la modelizacion del mecanismo de mantenimiento que tiene lugar a
lo largo de la vida de cada persona, y en virtud del cual en peque~nas regiones del
esqueleto el hueso viejo es reemplazado por el nuevo de manera que la cantidad total
de hueso permanece constante.
En concreto, en el captulo 2 se formula un modelo mnimo para el funcionamiento
de las llamadas BMU (Basic Multicellular Units), grupos de celulas diferenciadas
que actuan coordinadamente para eliminar hueso en regiones marcadas para ello
(generalmente mediante se~nales emitidas por osteocitos, que actuan como sensores
mecanicos) y a continuacion generan una matriz extracelular que, tras su mineral-
izacion, da lugar al nuevo hueso que reemplaza al antiguo. La actuacion de tales
unidades organicas es conocida desde los a~nos 60 del siglo pasado, y aunque su
esquema general de actuacion es conocido, y muchas de las se~nales qumicas in-
volucradas han sido identicadas, el mecanismo preciso por el que tales unidades se
forman cuando es necesario y se deshacen una vez cumplida su tarea, sigue sin ser
bien conocido.
En esta memoria proponemos un modelo operativo simple para BMUs, que se
basa en las siguientes hipotesis. En primer lugar, cada celula en una BMU puede
elegir una entre un numero muy limitado de posibles acciones a realizar (dividirse,
diferenciarse a otro tipo celular o morir). Tales decisiones no son aleatorias, sino
que estn reguladas por inhibidores internos especcos que bloquean cada una de
esas acciones, de modo que el primero de ellos cuya concentracion baja de un cierto
valor crtico determina de forma irreversible la accion a seguir. La dinamica interna
de estos inhibidores esta modulada por se~nales externas, provenientes en general de
otros tipos celulares presentes en la BMU. Mostramos en este captulo que basta con
un numero muy peque~no de tales se~nales (tres) para que el proceso resulte operativo.
En cualquier caso, cada celula decide individualmente lo que hace en cada momento,
sin que haya ninguna determinacion previa para ello, ni genetica ni de otro tipo.
1
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Sin embargo, el resultado de esta suma de decisiones individuales independientes
es una accion coordinada y perfectamente regulada, que permite remodelar la zona
elegida para ello de manera robusta y ecaz, como se observa mediante el analisis
de los resultados obtenidos al simular el modelo correspondiente, y que se presentan
en el mismo captulo. Los resultados obtenidos permiten formular cuestiones rela-
cionadas con la presencia detectada de un numero de se~nales mucho mayor que las
estrictamente necesarias, lo que probablemente esta relacionado con conceptos como
la multifuncionalidad (una misma se~nal induce diversos efectos en tipos celulares
distintos) y la redundancia (en el sistema considerado persisten diversos mecanismos
para alcanzar un resultado, que garantizan el funcionamiento del sistema cuando
uno falla, pero que representan un coste metabolico para las celulas involucradas).
El esquema que acabamos de resumir ilustra un aspecto de la metodologa seguida
en esta memoria, que tambien se usa en el siguiente captulo, y que nos parece par-
ticularmente relevante. En concreto, nuestro objetivo en cada uno de los problemas
estudiados es obtener modelos tan simples como sea posible, que permitan reproducir
los hechos observados y mas aun, que proporcionen indicios sobre el funcionamiento
interno de las estructuras consideradas que no han sido previamente incluidos en la
formulacion del modelo. Este enfoque es distinto de la estrategia habitual de mod-
elizacion, que busca incluir tantos datos biologicos como sea posible en cada modelo,
lo que conduce a una gran complejidad en los sistemas de ecuaciones obtenidos y
en particular hace precisa la introduccion de gran numero de parametros, sobre los
que se sabe muy poco. Ello obliga a elegir tales parametros para ajustar cada ex-
perimento concreto que se analiza, sin que se obtenga as un conocimiento real de la
dinamica involucrada, ni se pueda explicar de manera convincente las razones de los
comportamientos observados.
En el tercer captulo de esta memoria se estudia la sucesion de procesos que tienen
lugar en las etapas tempranas de la reparacion del hueso despues de producirse una
fractura, y que son cruciales para una completa curacion del mismo. Se proponen
modelos matematicos que permiten estimar los tiempos caractersticos de tales pro-
cesos en terminos de sus parametros cineticos. Para ello, se analizan tales etapas
de manera separada, hasta la formacion del primer callo broso, que proprociona el
molde basico sobre el que posteriores procesos de remodelacion (no estudiados en
esta memoria) daran nalmente lugar a nuevo tejido oseo, plenamente funcional.
El modelo propuesto es de tipo modular, de modo que consiste en una con-
catenacion de modelos simples que se suceden uno a uno hasta completar la etapa
temprana de reparacion estudiada. Se comienza por describir la formacion de un
coagulo sanguneo inducido por la fractura, cuya aparicion se caracteriza como una
transicion de fase tipo sol-gel, en la que el coagulo resultante es descrito como un
gel. La formacion de dicho coagulo, que debe conectar los bordes de la fractura
proporcionando una primera union entre ambos, es condicion necesaria para el exito
del proceso completo de reparacion . Describimos en primer lugar la generacion
de monomeros de brina a partir de la activacion de su precursor inactivo presente
en la sangre (brinogeno) mediante la accion de trombina, liberada tras las roturas
vasculares inducidas por una fractura. Los monomeros as formados se polimerizan
Universidad Complutense de Madrid
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rapidamente para formar grandes agregados. Usando la teora de polimerizacion
clasica, el proceso correspondiente puede ser modelado por un sistema innito de
ecuaciones de coagulacion-fragmentacion para los k-meros con k  1, en las que
los coecientes de coagulacion son proporcionales al numero de enlaces funcionales
libres en cada monomero. Dado que no es posible en general resolver las ecuaciones
anteriores, se recurre a la introduccion de una relacion de clausura para caracterizar
la transicion de fase buscada. Ello se hace sobre las ecuaciones para los momentos de
la distribucion de polmeros, en las que ahora es posible estimar de manera simple
el cociente M2=M1, que corresponde al tama~no medio molecular, de modo que la
transicion de fase buscada aparece cuando este cociente desarrolla una singularidad.
Se obtienen formulas para el tiempo de coagulacion que son explcitas en varios casos
y que permiten estimar el tiempo de coagulacion en el caso mas general.
Por otra parte, ademas de romper las moleculas de brinogeno, la trombina activa
a las plaquetas de la sangre, que cambian su forma liberando factores de crecimiento.
En este captulo se analiza el efecto inducido por un factor de crecimiento generico
g, que se difunde a traves del coagulo para atraer a las celulas mesenquimales. Estas
juegan un importante papel en la formacion del primer callo elastico, analizado en
este trabajo, y que proporciona el primer molde con estructura elastica suciente
para servir de base a posteriores procesos de osicacion no considerados en esta
memoria.
Tras proponer un modelo de tipo clasico para la difusion de g, se obtiene una
solucion explcita para dicha funcion, cuyo gradiente provoca el movimiento por
quimiotaxis de las celulas mesenquimales m desde el borde la fractura hacia su
interior. Se muestra que el perl del gradiente de g se estabiliza rapidamente y
puede aproximarse por una funcion lineal, siempre que el intervalo temporal no
supere al tiempo de vida media de las plaquetas. Se obtiene as una estimacion para
el tiempo TF de formacion del callo broso, que completa las obtenidas previamente
para otros tiempos caractersticos del proceso. Los resultados as obtenidos son
nalmente comparados con los existentes en la literatura.
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Abstract
This work is concerned with the mathematical modelling and simulation of bone
remodelling and repair. To this end, after a rst introductory chapter where a
number of preliminaries are gathered, we consider in Chapter 2 the modelling of
a homeostatic maintenance mechanism that is at work during a whole life, and by
means of which in small, targeted regions in the skeleton old bone is rst destroyed
and then replaced by new one, so that the total amount of bone remains constant.
More precisely, in Chapter 2 a model for the operation of the so-called Basic
Multicellular Units (BMU) is formulated. BMUs are groups of dierentiated cells
that act co-ordinately to destroy (resorb) bone in targeted zones, identied as such by
osteocytes, that are able to act as mechanical sensors, and then secrete extracellular
matrix which upon subsequent mineralization yields new bone to substitute the
previous one. The existence of such organic units is known since the sixties of
the former century and, while its general way of action is known, and many of the
chemical messengers involved have been identied, the precise manner by which such
units are formed when needed, and disbanded afterwards, remains to be ascertained
as yet .
In this memoir, a simple operative model for BMU operation is proposed. It is
based in the following assumptions. To begin with each cell in a BMU can only select
one among a very limited choice of actions (to divide, to die or to dierentiate into
another cell type). Such decisions are not randomly made, but are instead regulated
by specic internal inhibitors, which block each of these actions, so that the rst of
them that goes below a critical threshold irreversibly determines cell fate. The inter-
nal dynamics of such inhibitors is modulated by external signals, released by other
cell types present in a BMU. We show that a very reduced number of such signals
(actually three) suces to keep BMU at work. In any case, each cell individually
decides its course of action without resorting to any previously determined plan, ge-
netic or otherwise. Nevertheless, the outcome of this sum of independent individual
decisions turns out to be a coordinated and perfectly regulated course of action, that
leads to a robust and ecient remodelling of the zone involved, as can be seen from
analysis of the results obtained upon simulation of the model, that bare described
5
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in the same chapter. The results thus obtained lead to interesting questions related
to the detected presence of a set of signals much larger than that actually needed
for the model. This is probably related with aspects as multi-functionality (a same
signal may induce dierent actions in dierent cells) and redundancy (coexistence in
a same system of dierent mechanisms that yield the same result, thus ensuring a
security mechanisms against failure, though at the expense of a metabolic costs for
the cells involved).
The pattern described above shows one of the methodology characteristics fol-
lowed in this thesis, which is also used in the next chapter, and that we consider
especially relevant. Namely, our goal for each of the problems under study is to
obtain simple models which can recreate the observed facts. Furthermore, these
simple models will provide indications on the internal behaviour of the considered
structures, which had not been included previously in the formulation of the model.
This approach is slightly dierent to the usual modelling strategy that is to include
as much detail as possible, leading to typically very complex systems of equations
with a large number of parameters, most of which are unknown. This forces one
to identify such parameters for each specic analyzed experiment, without gaining
any real knowledge on the dynamics of the problem or explanation of the observed
behaviour.
In the third chapter of this thesis the processes which take place in the early
stages of a fractured bone repair are studied. These early stages are crucial for the
complete recovery of the bone. Mathematical models are provided to estimate the
time scales of these processes as a function of their kinetic parameters. To do so
the dierent stages are analysed separately, up to the formation of the rst brous
callus, which is the basic mould on which further remodellation processes will take
place (not studied in this work). This process ends with fully functional new bone
tissue.
The proposed model has a modular structure, formed by a sequence of simple
models which follow one another until completing the early stages of the bone repair
under study. Initially, the onset of a blood clot induced by the fracture is described as
a phase transition of sol-gel type, where the clot is represented as a gel. The formation
of this blood clot, which connects the edges of the fracture, is a necessary condition
to ensure the repair process is successful. The rst stage is the generation of brin
monomers from the activation of their inactive precursor present in blood (brinogen)
by the action of thrombin, which is released after the vascular breaks induced by a
fracture. The monomers which have just been created polymerise rapidly to form
large agglomerates. Following classical polymerisation theory, the above process can
be modelled using an innite system of coagulation-fragmentation equations for the
k-mers with k  1. The coagulation coecients are proportional to the number of
free functional bonds of each monomer. In general the mentioned equations cannot be
solved, thus the introduction of a closure relation to characterise the phase transition
is needed. This is done for the equations describing the moments of the distribution
of polymers, for which the coecientM2=M1 can be easily estimated. This coecient
describes the molecular mean size, therefore the phase transition will be present when
Universidad Complutense de Madrid
CONTENTS 7
a singularity appears in the coecient. Explicit formulas for the coagulation time
are obtained for several cases, and these provide an estimate for coagulation time
for a more general case.
Thrombin, apart from breaking brinogen molecules, also activates blood platelets,
which change shape whilst releasing growth factors. In this chapter the eect induced
by a generic g growth factor is analysed, which spreads around the clot to attract
mesenchymal cells. These play an important role in the formation of the rst elastic
callus (analysed in this work) that provides the rst elastically structured mould.
This mould is the building foundation for posterior ossication processes which are
not considered in this work.
A classical diusion model for g is solved, obtaining an explicit solution. The
gradient of g induces a chemotaxis movement of the mesenchymal cells m from the
edge of the fracture towards the interior. The prole of the gradient of g is shown to
stabilise rapidly and can be approximated by a linear function, as long as the time
interval does not overcome the half-life of the platelets. In this way an estimate of
TF is obtained, which is the time of formation of the brous callus. This completes
the estimates obtained previously for other characteristic time scales. The obtained
results are compared to those found in the literature.
Universidad Complutense de Madrid
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Chapter1
Preliminaries
1.1 Introduction
The human skeleton is a complex structure which provides a supporting framework
for the whole body. In addition, it acts as a shield to protect internal organs, serves as
a reservoir for a number of ions (particularly for calcium) and plays a crucial role in
body motion by mediating the transmission of force arising from muscle contraction.
Bone function is thus essential for human life, which makes important to keep bone
homeostasis by preventing, and when needed repairing , all kinds of bone disorders.
Out of the many bone-related hazards, bone fracture is a particularly relevant
one. About 1.5 million people suer a bone disease-related fracture each year in the
U.S [54], and recent studies claim that about 280 fragility-related fractures per hour
occurred in Europe's ve largest countries and Sweden in 2010 [52]. Such gures are
expected to keep increasing in the future, particularly in aging societies as developed
countries are.
In spite of such sobering data, it turns out that human bone has an impressive
capability for self-repair. In fact, our skeleton is continuously being renewed, so
that old bone is being destroyed in some places, to be eventually replaced by new
bone produced in the same locations. In that manner the whole skeleton is changed
every 10 to 15 years [37]. This self-renewal process, termed as bone remodeling, is
known to be triggered by local changes in mechanical load, and takes place at a
microscopic scale. Such repairing task is carried out in each case by a comparatively
small number of cells, that make up a Basic Multicellular Unit (BMU) [18] which is
mobilized for that purpose and then disbanded once its task is concluded. In fact,
BMUs are recruited when osteocytes, a characteristic bone cell type, detect that
mechanical stress goes locally outside of a range of admissible values [43].
A particular case in which the previous situation applies corresponds to the onset
of micro-fractures . These can be induced just by physical exercise (including walk-
ing ) and their occurrence (and ecient repair) is believed to signicantly contribute
9
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to keep bone remodeling in good shape [49]. However, when many micro-fracture
coalesce, or when a comparatively large fracture appears (for instance , as a conse-
quence of a traumatic event), BMUs turn out to be too small to take care of the
repairing process then needed , which has to be carried out at larger space and time
scales. To address the resulting new challenges, a number of strategies have been set
in place in the course of evolution. In particular, inammatory signals play now a
key role and a blood clot is formed that , upon serving as a rst bridge to connect
fracture borders, is subsequently remodeled to produce several callus with increased
stiness, which will be eventually replaced by new bone when the process successfully
concludes. It is worth to be noticed that, unlike other tissue healing processes that
leave scars when concluded, bone remodeling and bone fracture repair are scare-less,
so that no interface between old and new bone can be easily tracked. This seems
to be related to the fact that bone healing shares several characteristics in common
with the developmental program according to which ossication is carried out at the
embryonic stage [20].
In this memoir we shall address two problems, each related with one of the two
repairing events described before. To begin with, in our next Chapter 2 we will
provide a simple mathematical model that accounts for successful BMU operation
during standard, homeostatic bone remodeling. In that Chapter, BMU operation
will be described as an emergent behavior that can be derived from a reduced set
of assumptions on the possible individual choices of the cells involved in one hand,
and on the number of eective chemical cues mediating such decisions on the other.
Then in Chapter 3 we shall be concerned with fracture repair, in particular in the
case of fractures small enough so that theoretical results could be compared with
experimental ones, but beyond the range of BMU operation alone. In particular,
the onset of a blood clot will now be crucial and has to be taken into account in the
corresponding model. It will be shown there that preliminary (albeit in our opinion,
illuminating) estimates on the characteristic times of the repairing mechanisms can
be deduced from a simple set of assumptions concerning kinetic aspects of the early
stages of the corresponding bone healing process.
We have used several times the term simplicity when describing the goals ad-
dressed in this work. Indeed, a basic pattern in our approach consists in showing
that key aspects of the processes considered can be retrieved from the dynamics of
mathematical models where the underlying molecular and cell mechanisms have been
reduced to their minimal possible ingredients. No attempt to build comprehensive,
exceedingly complex models requiring of extensive parameter tting is made here.
We have rather chosen a dierent path, and in each case have tried to ascertain the
minimal number of mechanisms required to account for the processes considered.
The results previously sketched (in a very succinct manner) are to be found in
Chapters 2 and 3, as already mentioned. The rest of this introduction is devoted to
provide a number of preliminaries which will be later referred to in such Chapters.
In particular, we will shortly recall a few facts about bone structure in Section 1. 2
below. Additional information about bone remodeling and the role therein played
by BMUs can be found in Section 1.3, whereas a brief review of facts concerning
Universidad Complutense de Madrid
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bone fracture will be gathered in section 1.4. The emphasis in these sections is
on the biological facts underlying such processes. A short discussion on the use of
mathematical models to better understand the mechanisms involved is then provided
in Section 1.5.
1.2 Bone structure
The skeleton in vertebrates is formed by two tissues: bone and cartilage. In humans
the skeleton contains over 200 dierent elements that have been traditionally clas-
sied according to shape into long, short, at and irregular bones. Cartilage is the
conective tissue that can be found in the joins between bones. It is formed by cells
called chondrocytes that produce a large amount of extracellular matrix of collagen
bers. One of the main dierences between bone and cartilage is that bone is a
highly vascularized tissue and cartilage has virtually no blood vessels [51]. In this
work we are going to focus on bones and we will not study cartilage in deep.
The individual bones could be described at the macroscopic and/or microscopic
scales. At the macroscopic scale cortical and trabecular bone can be distinguished.
The cortical or compact bone is located in the outer surface of the bones, is harder,
stronger and stier than cancellous bone and contributes to the 80% of the weigth of
human skeleton [37]. The trabecullar or cancellous bone is found in the inner part of
at bones, is a highly porous, open-celled structure formed by interconected plates
and needle-like structures (named trabecullae) of bone tissue. The intertrabecullar
space is lled with marrow containing bloood vessels, nerves and several cell types.
In long bones the cancellous bone is located at the ends while in short bones or at
bones are located everywhere [37].
Figure 1.1: Bone macro-structure of the upper extremity of left femur. (Re-
produced according to the Creative Commons Atribution 3.0 Unported Licence
http://creativecommons.org/licenses/by/3.0/legalcode)
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At a microscopic scale bone has two dierent structures, lamellar and woven bone.
Lamellar bone is formed by concentric parallel layers of crystals and mineralized
hardened collagen in a system of short structures known as osteons or Haversian
system. This bone is a highly organized, anisothropic, and slowly formed material.
The woven bone is a fast formed and poorly organized material in which collagen
bers and crystals are more or less randomly distributed [37]. Most of bone tissue in
adult is lamellar, woven bone appearing mainly as a consequence of fracture healing.
Figure 1.2: Bone micro structure. Osteons are roughly cilindrical structures that are several
millimeters long and around 0.2 mm in diameter [17]. (Reproduced according to the Creative
Commons Atribution 3.0 Unported Licence http://creativecommons.org/licenses/by/3.0/legalcode)
Several cell types are present in the main stages of bone formation: osteo-
clasts, osteoblasts, bone lining cells and osteocytes. Bone lining cells, also called
pre-osteoblasts or surface osteoblasts, can be found in the periosteal and endosteal
surfaces of bones, whereas osteocytes (dierentiated osteoblasts) remain trapped in
the interior of the mineralized bone forming cavities named lacunae. Osteoblasts,
or bone forming cells, are derived form mesenchymal stem cells (as are bone lining
cells and osteocytes) and are located in the periosteum. The main product released
by osteablasts is type I collagen, but osteoblasts also secrete other noncollagenous
proteins. Osteoblasts form bone by facilitating mineralization but the mechanisms
by which this occur are not well understood [14].
Osteoclasts, or bone resorbing cells, are derived from hematopoietic stem cells.
Its main function is to destroy (resorb) mineralized bone and calcied cartilage. An
osteoclast is a multinucleated cell, and human osteoclasts on bone have ve nuclei
and are about 150-200 m in diameter [22]. (see Figure (1.3))
Bone develops by the process of ossication or osteogenesis. During this process
osteoblasts secrete osteoid, an amorphous material that gradually becomes densely
brous. Calcium phosphate crystals are deposited in the osteoid thereby becoming
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Figure 1.3: Bone cells that are present in the main stages of bone forma-
tion. (Reproduced according to the Creative Commons Atribution 3.0 Unported Licence
http://creativecommons.org/licenses/by/3.0/legalcode)
bone matrix. This last part of the process is termed mineralization. Two dierent
modes of osteogenesis are observed: intramembranous ossication, in which bone
formation occurs directly in primitive highly vascular connective tissue, and endo-
chondral ossication, in which bone formation takes place in pre-existing cartilage.
Endochondral ossication occurs in long bone formation (see Figure (1.4)) and in
fracture and osteotomy repair [13]. The terms intramembranous and endochondral
refers to the type of tissue being replaced, not to the type of bone synthetized, which
is the same in both cases [50].
Bone growth and remodelling are two dierent processes in the skeleton of verte-
brates. In the rst one bone is formed in sites where it was not present before, results
in changes in shape and/or architecture of the bones, and occurs since the rst stages
of fetal development until the second decade of life in humans [37]. The second pro-
cess, i.e. replacement of old bone by new one and reparation of microdamage [43],
takes place throughout the whole of life and, as we have already remembered, is re-
quired for mineral homeostasis, for adapting to mechanical changes and to maintain
the healthy functionality of bones.
1.3 Bone remodelling and the Basic Multicellular
Units
We have mentioned that bone growth and remodelling are two dierent processes, a
main dierence being the destruction of previously existing bone. The replacement
of old bone by new one is a process that involves resorption and formation of bone
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Figure 1.4: Formation and growth of long bones by endochondral ossication. Mesenchymal
condensation leads to a cartilage "model". Chondrocyte undergo apoptotic and cartilage mineral-
ization starts. Vascular invasion from vessels allows the migration of osteoblast precursor cells that
deposit bone on the degradated matrix scaold. (Reproduced according to the Creative Commons
Atribution 3.0 Unported Licence. http://creativecommons.org/licenses/by/3.0/legalcode)
without participation of a third tissue (i.e. case of endochondral ossication). Re-
modelling required for mineral homeostasis need not to occur in specic sites and
remodelling related to mechanical changes and damage is site-specic.
The resorption of bone is carried out by osteoclasts acting on small pockets
of bone and followed by osteoblasts precursors recruitment that dierentiate and
replace the resorbed bone by a suitable extracellular matrix (ECM) where bone
will be eventually produced. Resorption and formation processes are coordinately
carried out by discrete temporaly anatomic units called "Basic Multicellular Units"
(BMUs) rst described by Harold Frost in the sixties [21]. The region where BMU
operates, referred to as the bone remodelling compartment (BRC), is a canopy of
bone lining cells/osteoblasts and a nearby capillary covering the BMU [49].
BMU are present in cortical and trabecular bone and dier in structure and in
the ways they remove and replace bone. In trabecullar bone, BMU are located at
the surface covered by a canopy of cells of mesenchymal origin. The resorbing zone
is cleaned by lining cells and macrophages and osteoblasts precursors dierentiate
to ll the gap created by osteoclasts. BMU in the cortex display a moving team of
osteoclasts in it's front forming the cutting cone or hemicone, the remaining space
being lled by blood vessels, nerves and conecting tissue. (see Figure 1.5).
BMU move in three dimensions excavating and relling a tunnel in cortical bone
or a trench across the surface of cancellous bone. A cortical BMU travels about 4000
m at about 20 m=day, taking about 200 days to complete it's task. A cancellous
BMU travels about half this distance about half the speed, taking about the same
period of time to fulll that process [43]. The resorption period has a duration
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Figure 1.5: Remodeling is initiated within BRCs at points beneath the canopy of cells lining
trabecular bone (upper panels) and within cortical bone Haversian canals (lower panels). Osteo-
clasts (OCs) are formed from hemopoietic precursors (HSC) supplied by marrow and the blood-
stream. Precursors of osteoblasts come from MSCs in the marrow, from blood and from pericytes,
and dierentiate within the BMU through the osteoblast precursor stage to fully functional syn-
thesizing osteoblasts and to osteocytes; lining cells may also dierentiate into active osteoblasts.
T cells and macrophages can gain access to the BRC from the blood supply. (Reprinted by
permission from Macmillan Publishers Ltd: BoneKey Reports 3. Article number: 481 (2014)
doi:10.1038/bonekey.2013.215, copyright 2014)
between 30-40 days and is followed by the formation period with a mean duration of
150 days [18]. Remodelled regions can be recognized by cement lines that follow the
festoon-shaped surfaces that were eroded by osteoclasts [49]. In normal bone, the
result of this process is the complete relling of the resorption lacuna. The succesful
coordination of bone resorption and formation in each BMU is refered to as coupling
(see Figure 1.6). The mechanisms responsible for such coupling remain largely elusive
[18]. Any disturbance in coupling may result in pathologies as Osteoporosis, which
appears when osteoblasts are not able to fully rell the resorption region, so that a
net loss of bone occurs in each remodelling event. Conversely, Osteopetrosis (marble
bone disease) results when there is incomplete bone resorption [56].
The key event that triggers the remodelling process is osteocyte programmed cell
death or apoptosis, which has been shown to depend on mechanical load [41]. Thus,
osteocyte death characterizes the regions under high loading stress that require new
bone production, as well as the zones with lower mechanical demand where bone
should be removed. In the case of micro-fractures osteocyte death is induced, which
leads to subsequent activation of the bone remodelling process. In contrast, in large
bone fractures, osteocytes release alert signals that recruit immune cells and can
lead to an inammatory response, thus initiating an alternative pathway of bone
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Figure 1.6: Coupling between bone resorption and formation. The equilibrium between both
processes is condition for the repair of microscopical skeletal damage that occurs as a result of
constant ground impact. Figure courtesy of Dr. Jose Manuel Lopez.
formation that involves other cell types [4].
To this day the mechanisms of cell communication within a BMU remain only
partially understood. It's is clear however, that bone remodelling has to be tightly
regulated. For instance, an osteoblast should not start secreting osteoid matrix
before osteoclasts destruction task is nished. This raises at once the question of
how is this coordination achieved, and how could we possibly ascertain the internal
circuitry within a BMU that keeps it operative when remodelling is needed, and
shuts it o immediately afterwards. Those questions, once being claried, would
help us to understand the coupling between bone resorption and formation. This in
turn would greatly extend our current knowledge of bone homeostasis, the strategist
to preserve it, and possible methods to restore it when necessary.
1.4 Fracture Healing
The reparation of both bone micro-fractures and larger bone fractures are complex
processes that recapitulate aspects of embriological skeletal development [26], but
in the case of larger fractures there is a particular sequence of facts that have been
well documented. It consists of three overlaping phases termed as inammatory,
reparative and remodelling, each characterized by specic cellular, histological and
biochemical features. We next briey sketch them.
Right after bone breaking the resulting gap is lled with blood. Thrombin gener-
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ated by blood vessel disruption induces the cleavage of brinogen present in blood to
yield brin monomers, which actively polymerize afterwards. In this manner a brin
net is generated that in 6 to 8 hours connects both sides of the fracture, and provides
a rst scaold on which bone will be eventually produced [26], [16]. Soon after bone
fracture, a number of growth factors (BMP, VEGF, PDGF, ...) are liberated within
the fracture gap [5]. Such substances will mediate subsequent steps in bone repair
(Figure 1.7, A, B).
As soon as a brin clot begins to be formed, new functional blood vessels as
well as Mesenchimal Stem Cells (MSC) are recruited from the fracture boundaries.
MSC move in the wake of the new vascular bed created by incoming blood vessels.
The latter can be seen within 6 to 12 hours near fracture boundaries, and between
24 to 48 hours they have invaded the whole fracture gap [50].
MSCmove inwards from the fracture boundaries, and in doing so they experience
both symmetric and asymmetric divisions [36]. Symmetric division, whereby aMSC
gives raise to two MSC, takes place whenever their available initial number is not
enough to keep the healing process on time. On the other hand, when a MSC
reaches the brin clot it undergoes asymmetric division, thus giving raise to one
MSC and to one dierentiated cell, whose lineage depends on the density of the net
on which division takes place [10], [15], [48]. Cell replication is stimulated by some of
the growth factors present, whose action is dependent on the unfolding of the brin
clot (Figure 1.7 C, D). In particular, anchorage into the net signicantly extends the
half-life of growth factors with respect to that of freely diusing ones [53], [9].
Specically, the rst type of asymmetric division takes place over a low-density
brin clot and gives raise to broblasts. Once attached to the net, broblasts secrete
a number of substances (collagens) which stick to the clot and change its mechanical
properties [15], [48]. The resulting network (called brous callus) has larger me-
chanical stability than the earlier brin net, although not enough to ensure working
stability to the repairing bone (Figure 1.7, E, F, G).
In a period ranging from 48 to 72 hours, the fracture gap is lled withMSC and
their progenies ([32], [12]), which change as the composition of the net expanding
the fracture gap does so. In particular, upon sticking to collagen-enriched brin
net, MSC again undergo asymmetric division that now gives raise to oneMSC and
one chondrocyte ([36], [10]). This new type of cell interacts with the existing net
and produces a more stable compound, called cartilaginous callus (Figure 1.7, H, I,
J). Bone formation now begins in a subsequent remodelling phase. More precisely,
cartilaginous callus is replaced rst by trabecular and then by lamellar bone ([53])
through a process similar to endochondral ossication EO (Figure 1.7, K, L, M, N).
The micro-fracture healing is of intramembranous type and does not includes an
inammatory phase. In contrast with large fracture, in micro-fracture repair the
new bone is formed without resorting to the formation of a brin-collagen scaold
and is carried out by the action of the BMUs.
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Figure 1.7: Schematic representation of the fracture healing process. It is divided into four stages:
the initial inammatory response (A-B), soft callus formation (C-E), hard callus formation (F-I)
and bone remodeling (J-K). Figure courtesy of Dr. Jose Manuel Lopez
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1.5 Mathematical models
As in any other experimental science, what we know about a phenomenon is not
the phenomenon itself, but what our understanding, mediated by our language, is
able to formulate about the problem studied [33]. In the particular cases of fracture
healing and bone remodeling , there are several conceptual models that help us to
understand such processes. Some of them will be shortly described below.
Before doing that, a few remarks are in order. To begin with, when deriving
mathematical models , two possible (not necessarily conicting) goals may be pur-
sued. First, one might aim at proposing a set of equations whose solutions should
t a given set of data as closely as possible. One might instead intend that solutions
to the model could explain the phenomenon, in that they could be used to make
testable predictions that could be falsied by experiments. The rst approach looks
particularly appealing, and has perhaps been more actively pursued than the second
one. However, the history of science has many examples of mathematical models
that turned out to be wrong, even thoug they nicely t data, which they did by re-
sorting to a large number of equations or to a large number of parameters appearing
in them. A particularly well known case is provided by Ptolemy's theory of epicicles
introduced to t planetary motions, and many other examples can be found in dier-
ent scientic elds, as for instance in theoretical ecology [27]. Such attempts, which
showed great ingenuity, often managed to match actual observations. However, they
provided no explanation about the actual reasons for the facts observed, so that no
real insight on the processes considered was gained for their use.
In this work we shall adopt a dierent stance, and look for model simplicity as a
basic requirement to better understand the phenomena studied. We will thus keep in
line with Ockham famous dictum : among competing hypotheses, that with the fewest
assumptions should be selected [28]. Therefore , in each of the cases addressed we
will make explicit a minimal number of assumptions (that will always be biologically
motivated) required to explain the process being dealt with. Before doing that,
however, a short review of previous models on bone remodeling and fracture repair
will be discussed below. For the ease of presentation, such models can be classied
in dierent types as follows.
1.5.1 Mechano-regulatory models
It is widely accepted that mathematical modeling of bone function can be traced
back to the pioneering work by Roux [47] and Wol [55] in the XIX century. In
particular, W. Roux hypothesized that the biological processes of bone formation and
remodeling are regulated by cell signals generated by mechanical loading, a statement
considered as the fundamental premise for mechano-biology [38]. He further proposed
that cells within a tissue compete for functional stimulus. On his side, J. Wol
further elaborated the idea that changes in bone structure and shape are a direct
consequence of changes on the mechanical stresses acting on bone, a statement that
goes (under various versions) under the generic name of Wol's law. Such general
postulate has not remained free of controversy. For instance, according to Cowin [11],
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it considers as identical objects that are not so, as for instance stress trajectories in
a homogeneous isotropic material and the trabecullar structure of cancellous bone.
This fact notwithstanding, the assumption of a close link between stress induced and
bone structure has remained an inspiring principle in many later studies.
As a matter of fact, the literature on mathematical modeling of bone function
and repair has been steadily increasing since the sixties of last century, when the
availability of fast and ecient computers allowed for an easier comparison of nu-
merical solutions and experimental data. To classify such models, it has become
usual to consider the type of stimuli, mechanical or biological, which is considered as
more relevant in each case [25]. Such cases will be respectively termed as mechano-
regulatory and bio-regulatory.
Concerning the rst type, a breaktrough is usually credited to the work done by
Pauwels about 1960 [44]. Based on Roux's ideas, he proposed a theoretical framework
according to which mechanical forces acting on tissues determine cell dierentiation
pathways on such tissues . In particular, he postulated that distortional shear stress
is a specic stimulus for the development of collagen bers, and that hydrostatic
compressive stress is a specic stimulus for cartilage formation. According to this
author, bone formation requires of a stable, low-strain mechanical environment and
endochondral bone formation only occurs after soft tissues have stabilized their en-
vironment to that end. Pauwels theory has some limitations though. For instance,
no specic stimulus for bone formation is proposed, and his author was not able to
measure (or to estimate) in detail actual bone strains or stresses.
Further steps were provided by later models due to Carter et al. [6] and to Claes
and Heigele [7]. In these works biological tissues were considered as linear elastic
materials, and the formation of bone, cartilage and brous cartilage was related to
hydrostatic stress and to principal strains. In [6] the case of cyclic mechanical loading
was also considered. Dierent tissue dierentiation mechanisms were proposed by
Prendergast et al. [45], who considered biological tissues as poroelastic materials
and linked dierentiation into bone, cartilage or brous tissue to dierences in uid
ow properties and distortional strains. Subsequently, numerical studies based on
the approach proposed in [45] were conducted by Huiskes et al. in [30]. Finally,
a fuzzy logic theoretical model was proposed by Ament and Hofer in [1], in which
mechanical stimulus was evaluated by means of a strain energy.
A common feature of the works just mentioned is the extensive use of numerical
simulations to compare results corresponding to dierent bone repair situations with
experimental data.
1.5.2 Bio-regulatory models
A dierent approach to bone remodeling was introduced in work by Bailon-Plaza
and van der Meulen [2]. These authors proposed a mathematical model where the
eect of chemical cues, particularly growth factors, in bone remodeling was intro-
duced. Ever since, models where chemical signals are the most relevant players
retained are customarily termed as bio-regulatory. In [2], the action of growth fac-
tors on intramembranous and endochondral ossication was discussed. To do that,
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authors formulated a PDE system involving seven variables, namely the densities
of mesenchymal stem cells (MSCs), osteoblasts and chondrocytes, concentrations
of chondrogenic and osteogenic growth factors, and densities of connective/cartilage
extracellular matrix (ECM) and bone ECM. Authors considered processes as cell dif-
ferentiation, proliferation, migration and death, as well as synthesis and resorption
(destruction) of bone tissue. A number of interesting conclusions about the regula-
tory role played by growth factors in bone healing were drawn from the numerical
simulations performed.
In 2008, Geris et al. presented in [24] a model based on previous work in [23] which
includes additional features as the impact of angiogenesis (that is, the recruitment of
new vessels from a pre-existing vasculature) on bone repair. To that end, additional
variables were introduced to those already considered in [23]: density of endothelial
cells, broblasts concentration, vascular matrix and brous tissue densities as well
as a generic angiogenic growth factor. In that way a model was arrived at containing
12 variables in a similar number of coupled PDEs with 73 parameters in all.
The cases considered in our two previous paragraphs focused mainly on mechan-
ical or biological regulation of ossication and bone repair. It is natural to consider
the possibility of integrating both approaches, thus leading to what are known as
mechano-bio-regulatory models. A signicant step in this direction was provided by
Bailon-Plaza and van der Meulen in [3]. Building on their previous work [2], they
presented there a framework which specically incorporates the eect of mechanical
stimulus on cell activity. This approach, which naturally results in increasing levels
of model complexity, has been later pursued by many authors ( see for instance[39],
[46]). Besides there are models for bone remodelling that represent remodeling on
the scale of an individual basic multicellular unit (BMU) ( see [35], [35]), and models
that extending the later ones, include the osteocyre population to acomodate the
eects of mechanical loading [40]. However, we shall refrain from adding further
details here since we intend to explore a dierent approach in this memoir. In-
stead, further relevant information of previous work will be provided in the following
chapters where adequate.
It follows from our previous remarks that the quest for comprehensive models,
where all biological process known to date are included , necessarily leads to large
systems of equations with an even larger number of parameters (representing reac-
tion rates, diusion coecients, etc) which are basically unknown. It is natural to
select them so that a particular experiment could be satisfactorily tted. However,
most often the values thus obtained should be changed if a dierent experiment
is considered, and in general little insight can be gained in this manner about the
internal logic of the process under consideration. As we have already mentioned,
one could however try a dierent approach, and look instead for the minimal set of
biological ingredients that have to be retained in a model so that it can reproduce
what is actually observed. See for instance [19] for an example of a bio-regulatory
model in this vein. See also [29] for a survey of mathematical techniques to deal with
bio-regulatory models.
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Chapter2
Bone remodelling
2.1 Introduction
It is well known that bone microscopic structure continuously adapt to meet the
resulting mechanical requirements. This adaptation is achieved by means of a bone
remodeling process that is maintained throughout life, and whose control relies on
osteocytes, the most abundant cell type in bone [1, 2].
Osteocytes act as mechanosensors that monitor mechanical stress within bone
tissues, reacting to changes in both the amount and the direction of loading on
bone and ensuring that remodeling only takes place where needed. The key event
that triggers the remodeling process is osteocyte programmed cell death or apop-
tosis, which has been shown to depend on mechanical load. The relation between
osteocyte apoptosis and load applied is U-shaped, i.e., mechanical stresses within a
normal physiological range prevent it, whereas those above or below this range favor
it [3, 4, 5]. Thus, osteocyte apoptosis is a marker both for regions under high loading
stress that require new bone production, and for zones with lower mechanical de-
mand where bone should be removed. Micro-fractures, which are continuously being
produced as a consequence of physical exercise in healthy individuals, also result in
osteocyte apoptosis and subsequent activation of the bone remodeling process. In
bone fractures, a considerable amount of osteocytes are compromised and alert sig-
nals are produced that recruit immune cells and lead to an inammatory response.
In this manner an alternative pathway of bone formation is started where other cell
types are involved [6]. We shall not deal with this second situation here, since we
will be concerned with homeostatic bone remodeling at comparatively smaller scales.
The way in which this process is carried out is now discussed below.
Once triggered by osteocyte apoptosis, a bone remodeling process is executed
by organic teams called Basic Multicellular Units (BMU) [7]. Each BMU consists
of several morphologically and functionally dierent cell types (mainly osteocytes,
osteoblasts and osteoclasts) that act co-ordinately in small cavities, called Bone re-
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modeling Compartments (BRC) where remodeling takes place [8, 9]. The behaviours
of the dierent cell types involved can be summarized as follows. A normal pres-
ence of osteocytes keeps osteoblasts deactivated and precludes osteoclast precursors
from being recruited. When a group of osteocytes undergoes apoptosis, a drop in
inhibitory action results that has several consequences. In particular, it leads to
osteoblasts activation and to the attraction of osteoclast precursors arising from the
bone marrow. These precursors subsequently dierentiate into mature osteoclasts,
which start destroying surrounding bone, leading to the appearance of the so-called
cutting cones [10]. In a later stage of the process, activated osteoblasts, marching
in the wake of bone-destroying osteoclasts, will replenish the cavity left behind the
latter with an osteoid matrix. Some of the active osteoblasts remain trapped in the
bone matrix and dierentiate into osteocytes [11], which in turn will be instrumental
in the subsequent mineralization of the matrix surrounding them, thus concluding
local bone remodeling. The whole process is summarized in Figure 1.
Figure 2.1: A sketch of BMU operation after a group of osteocytes has
undergone apoptosis near bone surface. Left) Bone interior (in gray) contains
a number of functional osteocytes (OCY, in green). Apoptotic osteocytes (aOCY,
in black) cease to release osteoblasts (OBL) inhibitors, which in particular leads to
the activation of OBL placed at the bone surface. Center) A remodeling process
starts. As a further consequence of the drop in OCY-induced inhibitory eects,
Osteoclast precursors are recruited and dierentiate into active osteoclasts (OCL,
in red). OCL then form cutting cones that start the destruction (resorption) of
surrounding bone. Later on, activated osteoblasts (OBA) move inwards in the trail
open by OCL. Right). When the bone-remodeling compartment (BRC) reaches a
large enough size, OCL die by apoptosis and OBA secrete osteoid matrix. OBA
then dierentiate into OCY and remain trapped in that matrix, which is eventually
mineralized, thus completing the formation of new bone.
The process just recalled is exquisitely regulated. For instance, in addition to
taking place only where is needed, the amount of new bone generated should equal
that of old bone destroyed. Achieving such a balance requires of a coordinated action
of all cell types involved. To this day, and in spite of substantial progress achieved
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during the last 50 years, the mechanisms of cell communication within a BMU remain
only partially understood. It is known however that such regulation is of a local
nature since remodeling, which is continuously taking place, is simultaneously and
independently occurring in dierent parts of the skeleton [12]. The process under
consideration is a consequence of individual cell decisions. In fact, at any place where
the process is going on, individual cells within a BMU are not aware of the pace at
which remodeling is proceeding. Nevertheless, to eciently fulll its function, any
such cell should perform its task according to a precise schedule. For instance, an
osteoblast should not start secreting osteoid matrix before osteoclasts destruction
task is nished. This naturally raises the question of how is this timing achieved,
and what internal circuitry within a BMU keeps such unit operative when remodeling
is needed, and shuts it o immediately afterwards. We shall address these issues in
the following sections.
Specically, in this work we formulate and analyze a simple, space-dependent
mathematical model that is able to describe BMU operation. Simplicity is here a
key issue. We assume that any cell type within a BMU can only take a very limited
number of actions (divide, die, dierentiate) each being blocked within that cell by a
specic inhibitor molecule. The internal dynamics of such inhibitors is coupled with
the external medium via a minimal number of cell-to-cell signaling cues, which upon
binding with membrane receptors act as sources or sinks for the internal inhibitors.
The rst of them which falls below a threshold value determines a decision within the
previous list in each cell. We will show that only three signaling molecules, acting on
cells that can select one between at most three options, are enough to keep a BMU
fully operational. Other than choosing a given cell fate over another, cells in a BMU
move in response to environmental signals. For instance, osteoclasts form cutting
cones by moving inwards into the bone to be resorpted. On the other hand, active
osteoblasts lying behind cutting cones will eventually move in the opposite direction
during bone formation stage. This dynamic aspect of BMU operation will also be
included in our mathematical model.
Once our approach has been stated, a few remarks are in order. To begin with,
one may wonder how three signaling cues can possibly be enough for our purposes,
taking into account that a much larger set of mediating molecules have been de-
scribed in the context of bone remodeling (some of them will be recalled below for
convenience of the reader). We believe that this is related to some features of the
signaling network involved that are far from being fully understood as yet. Namely,
we refer to multi-functionality (the fact that a given signal may induce quite dierent
eects in dierent cell types ) and redundancy ( the presence of several molecules
that may produce the same eect in a given cell type). We do not aim here at pro-
viding a priority list between the signals described. What we show instead is that
three such cues are enough to regulate the internal inhibitors of the cells considered,
so that BMU operation results as an emergent property of the individual decisions
taken by any cell involved. Interestingly, such inhibitors have been described in the
literature, and the actions induced by the signals proposed have been associated to
various of the molecules identied in bone remodeling. We shall provide additional
Universidad Complutense de Madrid
CHAPTER 2. BONE REMODELLING 32
details on these topics in our next section.
A consequence of the previous remarks is that we do not aim at providing a
comprehensive model of bone remodeling where most (if not all) possibly involved
processes are retained, but rather at identifying the minimal BMU software required
to keep such unit operative. We believe that this may be a useful complement to
previous mathematical models available (see for instance [13, 14, 15] and references
therein). In these works, great attention is paid to include as many biological data
as possible in the models considered, which in particular leads to dicult problems
related to actual parameter tting for the processes involved. In spite of such obsta-
cles, and as a consequence of authors ingenuity, quite interesting results have been
obtained in such (and other) references. We hope that a combined use of both ap-
proaches (comprehensive and minimality -driven) could shed further light into our
understanding of bone remodeling , and particularly on its control when such type
of action would be required .
We conclude this introduction by describing the plan of this work. We rst
recall in Section 2.2 below some known results about cell types involved in BMU
functioning, their internal inhibitors and some of the main chemical signals that
have been described to mediate bone remodeling. In Section 2.3 we then formulate
our mathematical model which is subsequently simulated in Section 2.4 to yield a
number of results. In particular, we discuss there the manner in which the number
of cells in a BMU is determined by the BRC size, describe how osteoclast lifespan
depends on the depth of the BRC and show that the BMU circuit proposed is robust
to external noise. The paper then concludes with a Section 2.5, where our results
are discussed and possible future directions are shortly described.
2.2 A minimal software for BMU operation
In this section we shall briey recall some of the chemical signals that are known
to be involved in bone remodeling by BMUs. Specically, a list will be provided of
the main molecular mediators in BMU operation currently known, and of the eects
they induce in the dierent cell types involved. In-depth reviews can be found, for
instance, in [8, 16, 17, 12].
2.2.1 The role of molecular signals in bone remodeling
A considerable number of chemical signals involved in BMU actions have already
been identied. For instance, sclerostin is secreted by normal osteocytes and is known
to inhibit both osteoblast activation and osteoclast recruitment from precursor cells
in the bone marrow [8, 18]. This inhibitory eect prevents the activation of BMUs in
regions where bone remodeling is not needed. In fact, only when a sucient number
of osteocytes undergo apoptosis in a given area, due for instance to micro-fractures
or changes in mechanical load, will the inhibitory eect of sclerostin be removed, thus
entailing the activation of a BMU and the subsequent initiation of a bone remodeling
event.
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A set of signals known under the generic name of Bone Morphogenetic Proteins
(BMPs) have been described to play a key role during the rst stages of bone re-
modeling. Some members of this family, such as TGF- and TGF-, are known to
foster dierentiation of mesenchymal stem cells to osteoblasts [19, 20]. TGF- can
also induce migration of osteoblasts to the sites of bone formation during remodeling
[21] and inhibits osteoblast apoptosis [4]. TGF- is mainly produced by osteocytes
[18, 22], but it is also present in the bone matrix [19] and in platelets [23]. This
last factor, together with other signals such as HMGB-1 [6] provide a link with in-
ammatory processes occurring at early stages of larger fractures repair. Cytokines
such as IGF-1, released from bone matrix, seem to play a similar role in activating
osteoblast dierentiation [21] and are necessary for their survival in vitro [24].
The next stage in the process consists in the recruitment of osteoclasts to the site
of bone remodeling. The main signals involved in this step are M-CSF and RANKL
[25, 26, 17], that promote the dierentiation of osteoclast precursors and the survival
of activated osteoclasts. Since RANKL is mostly produced by activated osteoblasts
[8, 25], osteoclasts will only be recruited to sites were bone remodeling has already
been triggered. Furthermore, in case of a contingent activation of osteoclast precur-
sors where bone remodeling is not necessary, osteoclasts will die by apoptosis in the
absence of activated osteoblasts nearby. This provides a security mechanism that
avoids the presence of active osteoclasts out of the context of BMU operation. The
release by inactive osteoblasts and osteocytes of osteoprotegerin (OPG), a molecule
that inhibits the action of RANKL on osteoclasts [25, 26, 27], can also be understood
as a checkpoint mechanism that ensures that osteoclasts will only be activated and
kept alive in the presence of a sucient number of activated osteoblasts. Besides
inhibiting osteoblast activation, sclerostin also induces apoptosis of active osteoclasts
[8, 18]. It may thus act as a signal that stops bone resorption when the cutting edge
has reached the required depth in each remodeling event. Finally, osteoid matrix pro-
duction by active osteoblasts, as well as dierentiation of osteoblasts into osteocytes
seem to be cell-density dependent [28], and have been suggested to be mediated by
connexin, a molecule that circulates through gap junction communications between
osteoblasts, as well as by sclerostin [16, 29].
Concerning signalling eects, one also has to bear in mind that: I) dierent signals
can have redundant eects; for example both TGF- and IGF-1 induce osteoblast
dierentiation [21], II) a same signal can have dierent, even opposite, eects on
dierent cell types. For instance TGF-, FGF and PDGF activate osteoblast and
inhibit osteoclast action [23] and G-CSF is known to induce apoptosis and to inhibit
dierentiation in osteoblasts [26], and III) signals are not always provided by chem-
icals. In this context we have already remarked that osteocytes act as sensors that
respond to changes in mechanical stress in bone [27, 31].
The list just provided of molecular mediators and their eects on BMU cell
types, which is summarized in Table 1 below, is far from being complete. Moreover,
knowing the identity of molecular mediators or describing their eects in qualitative
terms is not enough to explain BMU operation during bone remodeling. In order
to understand how a coherent collective plan of action emerges at a multicellular
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scale, it is also necessary to take into account quantitative aspects of the process.
Indeed, for any given set of signals involved, the amount of bone to be resorpted
and produced in dierent remodeling events can be highly variable [8]. This implies
in turn that the number and activity of cells recruited in a BMU should change to
suit the needs of each particular remodeling process [22, 23, 30, 32]. Notice also that
the references quoted do not focus on quantitative aspects of the process, such as
the rate of the production of signals by BMU cell types, or their eect at dierent
concentrations.
Signal Source OCL OBL OBA
HMGB-1 aOCY
Recruitment
Chemotaxis
Recruitment
Chemotaxis
Chemotaxis
RANK, OPG
M-CSF
OBA
aOCY
Recruitment
Activation
Survival
- -
Sclerostin OCY Inhibition
No proliferation
No dierentiation
Apoptosis
No proliferation
No dierentiation
Apoptosis
TGF-
BMPs
PDGF
IGF
FGF
OCY
OBL
OBA
Inhibition
Chemotaxis
Recruitment
Dierentiation
Proliferation
Survival
Chemotaxis
Dierentiation
Proliferation
Survival
Table 2.1: A brief summary of the main signals involved in BMU operation as
described in the literature (see references in the text)
In our view, the key to understand BMU operation is signal integration by indi-
vidual cells, as discussed in the next section.
2.2.2 Signal integration by individual cells. Inhibitory pro-
teins
We now postulate our basic modelling assumptions, which can be summarized as
follows. Cells within a BMU integrate the molecular signals in their immediate
surroundings and, based on the information conveyed by these signals, they chose one
among a very limited set of actions, namely dierentiation, cell division, migration
and apoptosis. In addition, we postulate that inhibitory proteins, that block the
progression of these actions within each cell type, mediate cell decisions in any bone-
remodeling event.
This last assumption is illustrated by the well-known behaviour of two inhibitory
proteins, Rb and Bcl-2. The retinoblastoma protein (Rb) arrests progression into the
cell cycle, whereas the B-cell lymphome-2 protein (Bcl-2) precludes the initiation of
the apoptosis program in most cell types, including osteocytes and other stromal cells
[27]. More precisely, Rb binds to transcription factors of the E2F family, preventing
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the progression of the cell cycle to the synthesis stage [33]. When the amount of active
Rb falls below a critical threshold, a no-return point is reached (the Restriction
Point of the cell cycle) that irreversibly leads to cell division. Analogously, Bcl-2
precludes the release of cytochrome c through the mitochondrial outer membrane,
thus avoiding the initiation of the apoptosis program. If Bcl-2 is depleted beneath a
suitable value, its inhibitory action is lost and the cell is committed to die [34, 23].
Hence a competition between inhibitory molecules results in a mechanism of cell fate
control: the rst of these inhibitors (Rb or Bcl-2) that falls below its corresponding
threshold value determines the cell decision to divide or die and, importantly, the
timing of such decision (see Figure 2.A). This mechanism also provides an explicit
link between external signals and cell decisions, given that membrane receptors are
known to modulate the evolution of inhibitory molecules within the cell [34]. As a
matter of fact, it has been recently shown that the interplay between receptor/signal
interaction and the internal dynamics of Rb and Bcl-2 suces to explain the onset
of emergent population properties (as clonal expansion and contraction) in the case
of immune response to acute infections [35].
We suggest that a similar approach can be implemented to unravel a BMU op-
erational mechanism. For instance, the existence of inhibitory proteins controlling
cellular processes during bone remodeling is well documented in the literature. In
fact, two restriction points have been identied in the dierentiation program of os-
teoblasts (marking respectively the transition to activated osteoblast and osteocyte
types) that lead to the arrest of the process in the absence of the right signals [23].
One of these restriction points is determined by the inhibition of the transcription
factor Runx2 [36] by the action of proteins of the Twist family [37]. Moreover,
TGF- and BMP signalling are known to mediate Runx2 dynamics, thus modulat-
ing osteoblast dierentiation [38, 39, 40]. The increased complexity derived from the
presence of more than one cell type, together with the existence of several cell fates
(division, apoptosis or alternative dierentiation programs) now introduces new pos-
sibilities with respect to the basic dichotomy cell division vs. cell death considered
in [35]. However, the underlying logic can be extended to account for these new
alternatives. For instance, several inhibitory molecules can simultaneously block the
progression of alternative dierentiation programs. In this case, the rst inhibitor to
reach its critical threshold will unambiguously determine the fate of the cell (see Fig-
ure 2.B).We postulate that cell choices thus determined are mutually exclusive. This
seems to be the case for BMU cells. For instance, osteoblasts that start the dier-
entiation program or decide to secrete osteoid matrix do not complete the cell cycle,
and therefore do not proliferate [23]. We also remark that this mechanism allows for
one signal to induce alternative cell decisions depending on its concentration.
2.3 Mathematical modelling
Bearing in mind the multiplicity of signals recalled in Table 2.1, as well as the redun-
dancy often observed in their functioning, we propose that the eective operation
of a BMU can be modelled by means of a reduced version of the complex signalling
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Figure 2.2: A mechanism of cell fate determination. A) Inhibitory proteins Rb
and Bcl-2 provide a fate decision mechanism in several cell types. The rst of these
molecules to reach its critical threshold determines if the cell will divide or undergo
apoptosis. For convenience all inhibitory thresholds are set equal to zero. B) The
presence of inhibitors blocking alternative dierentiation programs allows to increase
the complexity of this cell fate-decision mechanism. B Left) If dierentiation is
assumed to be blocked by Inhibitor 1, which happens to vanish before Rb and Bcl-
2 do, then the cell will not divide or die, but will instead undergo dierentiation
program 1. B Right) Two alternative dierentiation programs can be controlled by
two dierent inhibitors (1 and 2). If one of them (inhibitor 2 in this case) disappears
faster than the remaining molecules, the corresponding dierentiation program is
selected.
network previously described. Specically, we propose that three cell-released sig-
nals, denoted by R, S and T suce for that purpose. The eect induced by such
signals in the cell types involved is described in Table 2.2 We will next describe the
main ingredients of the model proposed in this work.
2.3.1 Cell algorithms
In agreement with our main assumption in Section 2.2, we assume that progression
within the cell cycle, apoptosis and the initiation of dierentiation programs are
initially blocked by specic inhibitory molecules. This would allow for newly formed
cells to remain in the rst stage of the cell cycle (G1) before choosing a given cell fate.
During this stage, membrane receptors interacting with external signals dictate the
dynamics of inhibitors, thus controlling the eventual decision of the cell (see Figure
3). The eect of the complexes formed by membrane receptors and external cues
in the inhibition (resp. activation) of any cell fate choice takes place through an
increase (resp. decrease) in the amount of the inhibitory molecule controlling this
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Signal Source OCL OBL OBA
R OBA
Activation
Survival
- -
S OCY
Apoptosis
Inhibition
No proliferation
No dierentiation
Apoptosis
No proliferation
No dierentiation
Apoptosis
T
OCY
OBL
OBA
-
Proliferation
Dierentiation
Survival
No proliferation
Table 2.2: Generic signals to be considered in our model and a list of the
actions they induce on cell types of a BMU
choice. Cell fate is decided when the rst of the inhibitors considered reaches its
critical threshold.
Figure 2.3: Cell fate decision algorithm. A) The rst stage of the cell cycle
is a decision phase (dec). During this phase, membrane receptors interact with
specic external signals (S1, S2 and S3 in the picture). As a result, changes in
the concentrations of inhibitory molecules blocking progression into the cell cycle
(div), apoptosis (apo) and dierentiation (di) are induced. In the particular case
considered, signal S1 competes with S2 to induce and inhibit cell division respectively.
Signal S2 induces the initiation of the apoptosis program, while signal S3 leads to
cell dierentiation. Each inhibitor has a critical threshold (dashed line) that has to
be reached to trigger the corresponding cell action. B) Diagram of the cell decision
algorithm described in A). We remark that signals controlling cell fate do not need
to be produced by the cell itself. In this case, for instance, the cell releases signals
S1 and S3, while signal S2 is produced by other cell types.
The inhibitor dynamics will be assumed to be of the following form:
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8><>:
c0(t) = fc(R;S; T )
a0(t) = fa(R;S; T )
d0(t) = fd(R;S; T );
(2.1)
where c(t), a(t) and d(t) respectively denote the concentrations of division, apop-
tosis and dierentiation inhibitors at time t and fc, fa, and fd are functions of three
external signals S, R and T . For simplicity, we shall assume in the sequel such func-
tions to be piecewise linear, and will next describe the main details of the decision
algorithm for any cell type in a BMU.
Osteoblasts (OBL)
Osteoblasts (OBL) are initially located at the interface between bone matrix and
bone marrow. In normal conditions, osteoblasts homeostasis is maintained by a
continuous cell turnover, involving both division and apoptosis [41]. If a remodeling
process starts, osteoblasts can also dierentiate into active osteoblast (OBA). OBLs
can therefore choose among three alternative programs. In this work we will not
consider OBL division and apoptosis, which are therefore assumed to balance each
other during the process, and will focus on OBL activation during bone remodeling.
Activation is known to be mainly blocked by the release of sclerostin by osteocytes
[5, 8]. This will be modeled by assuming that signal S, produced by osteoctyes,
increases the amount of a dierentiation inhibitor in OBLs, denoted by dB , according
to the following dynamics:
(
d0B(x; y; t) = 
S1
B S(x; y; t)  S2B ; if dB < DB and box at (x,y) is adjacent to bone
d0B(x; y; t) = 0 otherwise;
(2.2)
where (x; y) denotes the position of the OBL, DB is the maximum amount of in-
hibitor that can accumulate within a OBL, S(x; y; t) is the amount of signal S at
location (x; y) at time t and 1B and 
2
B are positive parameters. During a bone re-
modeling process, osteoblasts remain in their original positions, delimiting the BRC
[9]. Accordingly, OBLs do not move in our model.
Active osteoblasts (OBA)
Once dierentiated, OBLs become active osteoblasts (OBA). OBAs have three pos-
sible choices: cell division, cell death and dierentiation into osteocytes (OCY). We
postulate that OBA division, apoptosis and dierentiation are inhibited by molecules
whose concentration are denoted by cA, aA and dA. Furthermore, we assume that
following activation OBAs can only divide, which leads to the layer of OBAs to pro-
gressively cover the surface of the cutting cone (see Section 2.3.2 below). We assume
that during this process the existence of OBA that are not in contact with the bone
surface blocks both the dierentiation of OBAs into OCY and their apoptosis. This
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can be achieved, for instance, by the interchange of molecules through gap junction
communications between cells. When all OBAs are attached to the bone matrix,
OBAs start to synthesize osteoid matrix, and can also dierentiate into OCY or die,
depending on the concentration of signal S in the environment. Dierentiation into
OCY will also be assumed to be blocked by cell contact with existing OCY, so that
only OBAs whose distance to OCY is larger that a threshold can dierentiate. These
behaviors are modeled by means of the following equations:
(
c0A(x; y; t) =  TAT (x; y; t); if box at (x,y) is not adjacent to bone
c0A(x; y; t) = 0 otherwise;
(2.3)
where (x; y) denotes the position of the OBA, T (x; y; t) is the amount of signal T at
location (x; y) at time t and 1A is a positive parameters.
When all OBAs are attached to the bone surface, cell division is no longer possible
for lack of space, and osteoid production, apoptosis and dierentiation into OCY can
take place, according to these equations:
8><>:
a0A(x; y; t) =  S1A S(x; y; t)
d0A(x; y; t) =
(
S2A S(x; y; t)  S3A , if distance to boxes occupied by OCY is less than A
0 otherwise
(2.4)
where S(x; y; t) is the amount of signal S at location (x; y) at time t and iA (for i =
S1; S2; S3) are structural positive parameters and A is a positive variable parameter.
Parameter A allows to model the eect of cell-to-cell contact inhibition by OCYs
on OBAs activation, resulting from gap junction communications between cells [8].
Osteoclast precursors (OCP)
OBA can recruit OCP to the bone remodeling zone by secreting signal R, while signal
S inhibits OCP recruitment. We will not consider in the model OCP division and
apoptosis, and assume instead that enough OCP are available in the bone marrow
(in particular, in the locations adjacent to those occupied by OBAs). OCPs attach
to the bone surface upon their recruitment by OBAs, after which they become active
osteoclasts (OCL). We assume that OCP activation is blocked by inhibitor dP , whose
dynamics is modeled as follows:
d0P (x; y; t) =  RPR(x; y; t) + SPS(x; y; t) (2.5)
where R(x; y; t) and S(x; y; t) are respectively the amounts of signal R and S at
location (x; y) at time t and 1P and 
2
P are positive parameters.
Osteoclasts (OCL)
Once recruited to the BRC, OCPs become active osteoclasts (OCL) and start dis-
solving the bone matrix, thus leading to the formation of a cutting cone. OCLs are
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assumed to be endowed with two alternative apoptosis pathways. One is controlled
by signal R and ensures that OCLs die in the absence of activated OBA. A second
pathway is controlled by signal S, produced by OCYs, and determines the depth
that will be reached by the cutting cone (the progression of OCLs into old bone is
described in Section 2.3.1). In particular, OCLs in locations with high concentrations
of S will stop digging into the bone matrix and die. We will model the apoptosis
pathway controlled by signal S by assuming that cell death is blocked by inhibitor
aC , whose dynamics is given by following equations:(
a0C(x; y; t) = 
S1
C if S(x; y; t) > 
S2
C
a0C(x; y; t) = 0 otherwise;
(2.6)
where S(x; y; t) is the amount of signal S at location (x; y) at time t and 1C and 
2
C
are positive parameters.
The algorithms just described for the cell types in a BMU are summarized in
gure 4.
Figure 2.4: A proposal for BMU software. Signals R, S and T (in small circles)
are produced by the cell types listed. They may inhibit (-) or induce activation
(+) on the actions considered. Activation results from double inhibition, that is by
lowering the concentration of an inhibitor. Within any cell type, possible decision
choices are indicated by thin arrows. Dashed arrows correspond to a starting decision
stage in a newly formed cell. Releasing of signals by any cell type (for instance, R
and T in the case of active osteoblasts) is denoted by thick, white arrows.
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2.3.2 Spatial dependence in the model
In order to account for the eect of signals on cell decisions within a BMU, the spatial
disposition of both cells and molecules should be explicitly taken into account. To
do that, we will consider a 2 dimensional cross-section of bone adjacent to a section
of bone marrow by means of a cellular automaton (CA). More precisely, the bone
section considered will be thought of as a lattice divided in boxes of equal size, where
any such box can either remain empty or be occupied by only one individual cell.
In addition, boxes can contain dierent amounts of chemical cues. The dynamics of
signals in the CA is summarized as follows. At any given time, they are produced
by the corresponding cell types at constant rates. Signals are also assumed to un-
dergo Arrhenius-type decay (meaning that their decay rate is proportional to their
concentration) and to diuse through the medium. We assume that diusion occurs
faster that internal cell processes. In order to account for these two time scales si-
multaneously, we model diusion by calculating, at each box and each iteration step
of the model, a weighted average of the amount of signals in neighboring positions
(see Figure 5.A). Cells need not remain conned to xed boxes in the lattice. Active
osteoblasts and osteoclasts can decide to move anytime during the simulation. Such
decision is made upon comparing the amount of dierent signals in their adjacent
boxes; details about the movement of each cell type will be provided below. As a
starting point we consider a population of osteocytes (OCY), regularly distributed
within the bone matrix, and a layer of osteoblasts lining the bone section (see Figure
5.B). Simulations of the model are started after apoptosis of a group of osteocytes
has occurred (see Figure 5.C).
2.3.3 Cell movements
In this section we will describe the movements of active osteoblasts and osteoclasts
during a bone remodeling event.
Active osteoclasts
After osteocyte apoptosis, osteoclasts are recruited into the BRC by active os-
teoblasts. Once activated, osteoclasts star to remove old bone, thus giving raise
to the appearance of \cutting cones", that may reach a variable depth into old bone
matrix, depending on the number of apoptotic osteocytes [22, 23]. We will assume
that osteoclasts remove bone at a rate that depends on the amount of signal S, thus
simulating the inhibitory eect that has been described for signals produced by os-
teocytes of osteoclasts activity [23]. We will assume that osteoclasts move to and
adjacent box once they have removed bone in their current position.
Bone resorption will be modeled by means of the following equations:8<:b0C(x; y; t) =  
S3
C (1 
S(x; y; t)
S4C
) if S(x; y; t)  S4C
b0C(x; y; t) = 0 otherwise;
(2.7)
Universidad Complutense de Madrid
CHAPTER 2. BONE REMODELLING 42
Figure 2.5: Spatial aspects of the model. A) Signal diusion takes place at a
dierent scale than cell decisions. Let t be the characteristic time step for cell
processes. In order to model signals diusion, we calculate the prole resulting from
cells diusing during this time interval. Diusion can then be modeled at this char-
acteristic time by applying the corresponding prole to any source of signals in the
CA. B) Snapshots of a signal diusion from the source shown in A. Time increases
from left to right and from top to bottom. C) Spatial arrangement of the main
elements of the model. Bone matrix is locally represented by means of a lattice con-
sisting of equal-size boxes, each able to accommodate one cell. The lower boundary
of the box considered in B is represented as lined with an osteoblast layer, lying
upon a layer of osteoclast precursors. D) Initial conguration of the model. At a
selected place within the bone matrix, osteocytes (blue dots) may undergo apoptosis,
thus triggering BMU operation in the corresponding region (blank). Lattice element
considered in B) is represented her for comparison purposes (see lower left corner).
Shades of blue represent dierent concentrations of signals in each box.
where S(x; y; t) is the amount of signal S at location (x; y) at time t and S3C and
S4C are positive parameters.
Active osteoblasts
Active osteoblasts move from their original position in the interface between bone
matrix and bone marrow to the inner surface of the cutting cone in order to secrete
new osteoid matrix. Osteoid production is also accompanied by active osteoblasts
movement, this time in the opposite direction. In our model, the movement of active
osteoblasts will be modeled as a consequence of cell division in the rst stages of the
bone formation phase. The production of osteoid will, in turn, entail the apoptosis
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and dierentiation of some of the activated osteoblasts, which will result in the
movement of the active osteoblast layer back to the position occupied by osteoblasts
before the remodeling event (see Appendix A and gures A.1 and A.2 for details).
2.4 Results
In this Section we present some results obtained upon simulation of the model whose
elements have been described in our previous Section. To keep the ow of the main
arguments here, we postpone some technical details to Appendix A at the end of
the paper. Specically, the reader will nd there a ow chart describing the order in
which the corresponding algorithms are applied, as well as a list of the parameters
used in the simulations whose results will be shown below. Concerning this last issue,
we wish to emphasize that no parameter-tting attempt has been made here. Our
concern is to show that the model proposed has not only the potential to reproduce
standard features in bone remodeling, but also to draw conclusions about the manner
in which this process is carried out that could not be a priori anticipated before
simulating that model. We will thus describe a choice of parameters for which such
goals are achieved, although we do not claim that these values are actual ones.
Parameters appearing in the actual BMU software should be of a structural nature,
and their precise values have to be determined experimentally. In fact, the circuitry
underlying BMU operation is expected to be rather sensitive to small variations
in such parameter values, a fact repeatedly observed in processes selected during
evolution. An example of such situation is provided by the Krebs cycle [42, 43]
which consists in a network of biochemical reactions taking place exactly at very
precise rates and proportions. We next succinctly describe some of the conclusions
drawn from the simulation of the algorithms described in Appendix A.
2.4.1 The BMU software proposed successfully recapitulates
bone remodeling
Upon induction of osteocyte apoptosis in a region, the cell algorithms proposed
sequentially describe the manner in which bone remodeling occurs there. See Figure
6 below.
2.4.2 The size of the BRC adapts to the number of apoptotic
OCY
The model proposed can be run when OCY apoptosis is assumed to occur in regions
of dierent sizes. In each case, the area of the corresponding Bone remodeling Com-
partment (BRC) is shown to depend on the extent of the induced OCY apoptosis.
See Figure 7.
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Figure 2.6: Snapshots corresponding to sequential stages in a bone remod-
eling event. A ) A planar bone region is considered where active osteocytes (OCY,
blue dots) are regularly distributed. Osteoblasts (OBL, in green) are located at the
lower side, which represents the interface between bone and bone marrow. B) OCY
apoptosis is induced in a subset (in white) of the previous region, which leads to a
drop in OCY inhibitory action in that place. C) Lack of enough osteocyte inhibition
results in OBL activation, and the recruitment of osteoclast precursors which dier-
entiate into active osteoclasts, OCL (in red). D) OCL form cutting cones that move
into the apoptotic region destroying old bone (bone resorption). E) OCL- driven
resorption proceeds until the inhibitory eect of the remaining osteocytes precludes
further OCL progression. F) Activated osteoblasts (OBA, in orange) move in the
wake of OCL. G) OBA move inward from the OCL- lined cutting cone boundary
secreting osteoid matrix. Part of them subsequently dierentiate into OCY (blue
dots). The limit of the cutting cone is shown in black. H) When remodeling is
nished, a new distribution of osteocytes is achieved in the remodelled region, and
I ) new bone is eventually formed.
2.4.3 Osteoclast lifespan depends on the depth of the BRC
A prediction of the model is that average osteoclast lifespan is not a priori deter-
mined, but depends instead on the size of the region where bone remodeling has to
be performed. This fact is illustrated in Figure 8 below, where mean OCL lifespan
is plotted in terms of BRC depth.
2.4.4 The BMU software is robust to signal noise
As we have seen above, the operation of cells within a BMU depends on cell-to-
cell communication by means of signals that diuse through the bone matrix. The
coupling of old bone resorption and new bone formation can therefore be aected by
signal noise due, for instance, to bone matrix spatial heterogeneity. In gure 9 we
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Figure 2.7: Simulation of three dierent scenarios of OCY apoptosis. Im-
ages correspond to results obtained in each case after the simulation of the model
since OCY apoptosis until the end of the remodeling process. The edge of the re-
sulting cutting cone is depicted in black. The shape and size of the resulting BRC
is determined in each case by the region where OCY apoptosis has occurred.
Figure 2.8: Dependence of OCL lifespan on BRC size. Left) A region where
bone resorption has occurred following OCY apoptosis is depicted. BCR depth is
dened there as the longest distance within that region measured perpendicular to
its lower side. Right) A plot of average OCL lifespan during bone remodeling events
in terms of BRC depth obtained after simulations of the model (each dot corresponds
to a simulation). Note that OCL live longer when BRC is larger.
show that the suggested BMU software is robust to environmental noise.
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Figure 2.9: Eect of signal noise in BMU operation. A) Simulation cor-
responding to a bone remodeling without noise in signal S diusion. The initial
situation is depicted in the left gure. The shape of the cutting cone is marked in
black. The region of apoptotic OCYs is shown in the center. The right picture cor-
responds to the new bone after remodeling. B) In spite of noise, both the resulting
cutting cone and the new distribution of OCY is similar to A. C) Histogram of the
rate between the number of newly formed OCY in the BRC after bone remodeling
with and without noise (the result was obtained after 200 simulation of the model).
2.5 Discussion
In this work we have proposed and analyzed a minimal model for bone remodeling
carried out by Bone Multicellular Units (BMUs) as part of their routine activity
to replace old bone by new one, a process which is often triggered by changes in
mechanical load. We have already recalled that such remodeling is continuously
taking place during human life, so that on average the whole skeleton is renewed
every 10 to 15 years [44]. BMUs activity is usually carried out at small regions, say
about 4000 microns in width [45] and therefore the total number of cells involved
in each remodeling event is comparatively small. The previous length scale can be
also used to characterize micro-fractures (arising for instance from physical exercise)
which are also self-repaired in the same manner. BMUs operation can thus be viewed
as the basic building block to keep homeostasis in bone tissue. When normal function
in bone is compromised by large-scale hazards (say, fractures), more sophisticated
repair mechanisms, involving in particular inammatory signals, blood clot formation
and the production of dierent callus templates for bone repair are involved, which
have not been discussed here.
Our goal in this work is to identify, by means of a mathematical model, a minimal
algorithm for BMU operation. To do this, we have kept to a few basic principles.
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First, at any time during that process, each cell within the dierent lineages present
in a BMU should individually decide one among a restricted set of actions: divide,
die or dierentiate. Such choice is not assumed to be random, but determined
by feedback from the surrounding medium into the internal dynamics of molecules
which act as decision inhibitors. No previous planning is presupposed, genetically
or otherwise. Second, only a minimal number of signals are selected that allow for
BMU functioning. As recalled in Section 2, all elements retained have been shown
to be actually in place in working BMUs. In particular, cell decision inhibitors have
been identied, and eects induced by the signals proposed have been shown to be
caused by chemical mediators experimentally detected. However, we have not aimed
at producing a comprehensive model where all data currently known could be tted.
We have instead attempted to show what the basic ingredients of an operational
BMU could be like. Implicit in this approach is the assumption that some signals
already identied are multi-functional (thus yielding dierent eects in dierent cell
lines ) and that in general some signaling networks observed can be redundant,
perhaps as a consequence of having been arrived at through dierent paths in the
course of evolution. Notice, however that we do not claim that our proposal is the
only possible one. In principle, there could be alternative minimal models for what
we have called a BMU software. We believe however, that the degree of complexity
retained in our model could not be signicantly reduced by alternative mechanisms.
Selecting a minimal model has the advantage of dealing with a comparatively
small number of parameters. Indeed, it is well known that a given phenomenon can
be tted by utterly dierent models, relying on dierent principles, upon appropriate
choices of a suitable (and often rather modest) number of parameters appearing in
them [46, 47]. We have shown herein that the parameters retained in our model
can be selected so that BMU standard operation is reproduced and, importantly,
consequences such as the dependence of osteoclasts lifespan on the size of the region
to be repaired can be inferred that were not a priori clear before the model was sim-
ulated. We do not claim, however, that the results obtained provide a validation of
the model. In our opinion, such validation could only stem from experimental deter-
mination of such values. This should be in principle possible, since most parameters
retained are of a structural character (see pseudo-code guidelines in Appendix A ).
By that we mean that such values correspond to coecients as for instance exter-
nal signals/internal inhibitors interaction or maximal inhibitor accumulation within
osteoblasts. Such performance rates might well have been evolutionary selected to
remain conned within very narrow margins, as is the case with virtually all robust
metabolic processes which have been unraveled so far [42, 43].
We conclude this discussion by briey remarking on possible future directions
arising from this work. To begin with, the experimental question of determining
the operational parameters introduced in our model should be again stressed. If
and when this is done, we would have in place a BMU chip structure to be used as
a building block for operational purposes. On the other hand, one could simulate
on models as that presented here the impact of external cues in the modulation
of the repair process, either to slow it down or to accelerate it. Finally, as the
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size of the region to be repaired increases, a threshold should be reached beyond
which inammatory signals become relevant, and a new and more complex stage is
entered. Understanding the matching between these two cases could be instrumental
in designing techniques to foster bone fracture repair. We intend to pursue some of
these subjects elsewhere.
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Chapter3
Early stages of Bone fracture healing
3.1 Introduction
Bone repair is a robust physiological process which is constantly acting in healthy
individuals. In particular, bone microfractures induced by exercise (including walk-
ing) are routinely self-healed without even being noticed, although large microfrac-
ture condensation may result in severe injury [39], [6]. Interestingly, bone self-repair
makes use of key ingredients of the developmental program responsible for ossica-
tion during the embryonic stage [19], [18]. The sequence of events occurring after a
bone fracture involves three phases: inammatory, reparative and remodelling, each
characterized by specic cellular, histological and biochemical features. The inam-
matory phase has received relatively lower attention then the other two, in spite of
its fundamental role in the subsequent evolution of the process.
In this chapter we propose and discuss a simple model to analyze the early stages
of bone fracture repair. When a bone fractures, several blood vessels break and a
mass of clotted blood is formed at the injury site. This fracture hematoma has a
little eect to stabilize the bone, but it provides a rst bridge between the two bone
fragments and thus keeps both pieces lined up for mending. A key ingredient in this
stage is the formation of the rst elastic, brin-collagen scaold (the so-called early
brous callus, EFC) which provides a rst consistent scaold for mesenchymal cells
to settle and dierentiate to broblasts, condrocytes and osteoblasts, to eventually
form a bony bridge between the two fragments. The corresponding process, which is
an essential starting point for subsequent bone healing, takes place in a comparatively
short period: no more than 48 hours in the case of thin induced fractures in mice [21].
More precisely, we shall pursue the following goals: (i) to estimate the characteristic
times of the main events leading to EFC formation, and (ii) to ascertain their
dependence on the kinetics of key underlying mechanisms as platelet activation, brin
polymerization and brin clot remodelling mediated by broblasts. We will not be
directly concerned here with mechanical eects, which become particularly relevant
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at later stages, as EFC becomes a cartilaginous callus (CC) on which dierent types
of bone tissues are formed upon remodelling of CC through a sequence of processes
which result in changes in the composition and mechanical properties of previous
scaolds [21], [20].
Our plan is as follows. In Section 2 below we review basic known biological facts
concerning the main events in fracture repair, particularly during the early stage to
be considered. We then discuss in Section 3 a mathematical model whose analysis
will allow us to estimate several characteristic times of the process under consider-
ation . The rst of them corresponds to the formation of a brin blood clot, the
earliest structure generated during the process of bone repair. The onset of such a
clot, which in spite of its poor mechanical properties provides a rst bridge to join
both sides of the fracture and is therefore crucial for bone repair [50] is character-
ized here as a phase transition in a polymerization event. Its timing is estimated
in terms of the various physiological processes (thrombin-induced activation, brin
polymerization,...) involved.
Once this brin network is in place, attention is paid to a rst , and crucial,
remodelling eect. This results from the release of collagen over the brin net,
which is deposited by broblasts arising from asymmetric division of mesenchymal
stem cells (MSCs) recruited from neighbouring regions (periostium). The timing of
this event is kept track of by means of the motion of a front of MSCs proceeding
inwards from the borders of the fracture gap. Such motion is chemotactically induced
by growth factors released by activated platelets trapped within the brin clot [54],
[24]. As it turns out, substantial insight about the process considered is derived from
the study of a particular asymptotic limit, namely the case where brin clotting is
triggered by an instantaneous thrombin discharge. Under such assumption, our
model can be explicitly solved, which permits a detailed discussion of the inuence
of the dierent biological processes involved. Estimates for the characteristic times
obtained in Section 3 are then provided in Section 4. Finally, a discussion on the
results obtained as well on possible future directions is gathered in a concluding
Section 5.
We point out that mathematical models of dierent aspects of ossication and
bone repair have received considerable attention in recent years [35],[2],[23],[16],[44];
for later repair stages see also [41], [40], [45]. Some issues similar to those addressed
in this work have been also discussed in related biological problems as wound healing,
which shares a number of features with bone repair [38], [42], [32] in particular during
the early stages here considered.
3.2 Basic facts on bone fracture healing. The rst
48 hours
When bone fracture occurs, damage is induced on a variety of tissues including
surrounding muscular cells and periosteum as well as on bone itself . Bone is a
highly vascularized tissue, and its fracture leads to many blood vessels acrossthe
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fracture line being broken . Blood then runs away from disrupted vessels to the
medullary canal between the fracture ends and rapidly coagulates to form a clot. On
the other hand, immediately after fracture the resulting necrotic material induces an
intense inammatory response including widespread vasodilation, plasma exudation,
edema and recruitment of acute inammatory cells [9]. As a consequence, a complex
hematoma is generated that is of major importance for the beginning of bone healing,
since it provides a rst bridge between separated fragments of bone [50]. Such
hematoma plays a very small mechanical role in immobilizing the fracture, but it
serves as a brin scaold and provides an adequate microenvironment over which
repair cells may settle to perform their function.
Formation of hematoma is a comparatively fast process. In the case of thin in-
duced fractures in rat tibia, a case which will be considered here for comparison
purposes, the fracture gap is about 2.5 mm in average, and hematoma can be ob-
served by optical microscopy at about 3 hours after fracture induction. See Figure
1 below.
Figure 3.1: Blood clot between the ends of a bone fracture. Bone tissue is stained in pink
whereas blood tissue has a brownish color. The immediate ends of the fracture border contain
necrotic material (arrows). Picture take from tibia from a 35 days old rat, 6 hours after fracture.
A key constituent of hematoma is a brin net. Immediately after bone breaking,
a coagulation process starts. Thrombin generated by blood vessel disruption induces
the cleavage of brinogen present in blood to yield brin monomers, which quickly
polymerize afterwards. In this manner a brin net is generated that in 6 to 8 hours
connects both sides of the fracture and provides a rst scaold on which bone will
eventually be produced [21], [15]. Importantly, when fracture occurs, a number of
growth factors ( BMP, VEGF, PDGF, .. ) are released within the fracture gap
[5]. Such substances will mediate subsequent steps in fracture repair.
As soon as a brin clot begins to form, new functional blood vessels as well as spe-
cic cell populations are recruited from the fracture boundaries. The cells involved
directly in the repair of fractures are of mesenchymal origin and of a pluripotential
nature. For deniteness we shall refer to such precursors as mesenchymal stem cells
(MSCs) in the sequel. MSCs move in the wake of the new vascular bed created by
incoming blood vessels. The latter can be seen within 6 to 12 hours near the fracture
boundaries and between 24 to 48 hours they have invaded the whole fracture gap
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[51]. See Figure 2 below where images taken 24 hours after fracture induction are
presented.
Figure 3.2: Early remodelling can be perceived in hematoma 24 hours after fracture, with brillar
material being found in some regions of the blood clot represented in pink (arrows). Bone depicted
in brown.
Figure 3.3: Image showing early invading cells derived from the cambium layer of the periosteum
at the border of the fracture 24 hours after fracture. Such cells show morphology of mesenchymal
cells (arrows).
Figure 3.4: Picture representing a EFC being formed 24 hours after fracture. An increasing
number of invading cells is observed (arrows) and partial reabsorption of the hematoma can be
noticed (stars)
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MSCs are chemotactically recruited from the fracture borders by chemical cues
released from activated platelets trapped in the brin clot [30] (see Figure 3.3).
MSCs may sustain either symmetric or asymmetric division [36]. Symmetric di-
vision, whereby a MSC gives raise to two new MSCs, takes place whenever their
initial number is not enough to keep the healing process in time. On the other hand,
when aMSC reaches the brin net, it can undergo asymmetric division, thus giving
raise to oneMSC and one dierentiated cell, which may be of various types: brob-
lasts, chondrocytes or osteoblasts depending on microenvironment stimuli and on
the stresses they are subject to [36] [61], [31]. In particular, such lineages are known
to depend on the density of the net on which division takes place [11], [14], [48]. Cell
replication is stimulated by some of the growth factors present, whose action is in
turn dependent on the unfolding of the brin clot. In particular, anchorage into the
net signicantly extends the half-life of growth factors with respect to that of freely
diusing ones [49], [60].
Specically, the rst type of asymmetric division takes place over a low-density
brin clot and gives raise to broblasts. Once attached to the net, broblasts secrete
a number of substances (collagens) which stick to the clot and change its mechanical
properties [14], [48]. The resulting network, called early brous callus (EFC) is in
place between 24 to 48 hours after bone break up (see Figure 3.4). It has larger
mechanical stability than its preceding brin net, although not enough to ensure
working stability to the healing bone. Such stability will be achieved through subse-
quent remodeling processes. In particular, upon sticking to a collagen-enriched brin
net, MSC can again undergo asymmetric division that now gives raise to one MSC
and one chondrocyte [36], [11]. This new type of cell interacts with the existing net
and produces a more stable compound, called cartilaginous callus. Bone formation
properly begins in a subsequent remodeling phase. At that stage, cartilaginous cal-
lus is replaced rst by trabecular and then by lamellar bone [55] through a process
similar to endochondral ossication. These later stages will not be considered in this
work.
3.3 A mathematical model for the formation of a
brin-collagen callus template.
In this Section we formulate and analyze a mathematical model to describe the early
stages of cartilaginous callus formation in a fracture. For simplicity we specialize
here to a one-dimensional case, and assume that the fracture gap is located at an
interval centered around the origin, say 
 =
  L2 ; L2 , with L > 0. Our model is
of a modular character, and contains a series of basic units which are activated in
sequential order. These will be described below.
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3.3.1 Generation of brin monomers upon thrombin-induced
brinogen cleavage.
Right after a fracture is generated, a number of substances arising from broken
blood vessels are allowed to enter in contact with leaked blood. The actual sequence
of biochemical events thus triggered is known to involve several agents [17], [43].
However, a common simplifying assumption consists in considering that complex
process as driven by the action of the enzyme thrombin (obtained from its inactive
precursor prothrombin) which cuts inactive brinogen molecules present in blood,
thus giving raise to brin monomers. The latter then quickly polymerize to produce
a brin clot. It is customary to describe thrombin generation by means of curves of
the form represented in Figure 3.5, below ([17], [8]).
Thrombin 
Concentration
Time (Min)
(A)
Thrombin 
Concentration
Time (min)(B)
Figure 3.5: Typical thrombin proles (adapted from [17], [8]). (A) About 95% of thrombin is
generated as a consequence of positive feedback processes involving coagulation factors FVIII,
FIX and FX [17], [37]. (B) dependence of thrombin concentration on time in some experimental
settings, when anticoagulant factors are kept below haemostatic levels [8].
As mentioned in the caption of Figure 3.5, the sequence of events leading to
thrombin generation include a number of feedback loops of an activator-inhibitor
nature involving several coagulation/anticoagulation factors ([17], [25], [27]). Given
that large uncertainties remain about the order and rates of the corresponding chem-
ical reactions ([12], [57]), we have resorted here to a simplied modelling approach,
which is now described. Let us respectively denote by F (t), (t) the concentration of
brinogen and thrombin (assumed homogeneous in space) at time t. We postulate
that brinogen is removed by thrombin according to a second order kinetics
_F =  kgF for some kg > 0, t > 0 (3.1)
whereas at t = 0, when fracture occurs, one has that
F (0) = FM > 0 (3.2)
for some physiological concentration FM . We now consider an asymptotic limit of
the prole sketched in Figure 3.5 A, namely the case of an instantaneous thrombin
discharge at t = TM > 0, that is:
(t) = C(t  TM ) for some C > 0 (3.3)
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where (t   TM ) denotes Dirac's delta at t = TM . Note that (3.1) and (3.3) rep-
resent a very fast chemical reaction for which the precise mathematical meaning of
the governing dierential equation has to be specied. In particular (3.1) is to be
understood here as stating:
d
dt
(logF ) =  kg
On integrating this equation and using (3.2) it follows at once that:
F (t) =

FM for t < TM
FMe
 kgC for t > TM
(3.4)
Fibrinogen molecules cleaved by thrombin give rise to brin monomers, which
subsequently polymerize to form large brin agregates. Using classical polymeriza-
tion theory ([53], [28], [25]) the corresponding process can be modelled by an innite
system of coagulation-fragmentation equations for the concentrations Fk(t) of brin
k-mers k  1
_F1 = kgF   F1
1X
i=1
a1iFi +
1X
i=1
b1iFi+1   krF1 (3.5)
_Fk =
1
2
k 1X
m=1
am;k mFmFk m   Fk
1X
i=1
akiFi +
1X
i=1
bkiFi+1
  1
2
X
i+j=k
bijFk   krFk; k = 2; 3; : : :
(3.6)
where akj , (respectively bkj) denote the coagulation rates between k-mers and j-mers
(respectively the fragmentation rate at which k-mers are produced from the break-up
of j-mers, j > k). Rates kr correspond to polymer deactivation, and will be assumed
to be independent of polymer length by simplicity. Assuming polymerization to
occur according to classical Flory-Stockmayer theory, so that no polymer rings can
be formed and coagulation rates are proportional to the number of the free available
sites in each polymer, it turns out that
aij = kp ((f   2)i+ 2) ((f   2)j + 2)
([25], [28]) where f denotes the number of active functional sites in a brin monomer.
Taking f = 4 ([59]) we eventually obtain
aij = 4kp(i+ 1)(j + 1) (3.7)
On the other hand, assuming (i) the probability of a molecule of length k being cut
by a fragmentation mechanism to be proportional to the number (k   1) of bonds
and (ii) the probability to form a molecule of length i out of fragmentation of a
molecule of length k (k > i) to be inversely proportional to the number of bonds, we
obtain ([25]) that:
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bij = 2kb for some kb > 0 (3.8)
A general discussion of the resulting system (3.5)-(3.8) is highly involved and will
not be pursued here. However, considerable insight into blood-clotting dynamics is
gained by making use of suitable auxiliary assumptions and simplifying hypotheses.
To this end, for any integer n  0 we dene the n-moment Mn of the polymer
distribution:
Mn(t) =
1X
k=1
knFk(t) (3.9)
Note that M1(t) represents the total mass of the polymer distribution once the
monomer mass has beeen normalized to one. Of particular interest here is the fact
that the ratio (M2=M1) corresponds to the average molecular size. In classical Flory-
Stockmayer theory a nite-time blow-up of that ratio marks the onset of a sol-gel
phase transition, whereby a gel phase appears ([53]). Bearing this fact in mind,
we say that a brin clot is formed as soon as that ratio develops a singularity at
some time ([28], [25]). Upon replacing kb by 3kb, it follows from (3.5)-(3.8) that the
moments M1, M2 satisfy:
_M1 = kgF   krM1
_M2 = kgF + 4kp (M2 +M1)
2   kb(M3  M1)  krM2
(3.10)
Note that such a system is not in a closed form, since the third moment M3 appears
in equation for M2. To obtain a well posed problem we now set:
M3 =
M22
M1
(3.11)
As observed in [25] where this closure argument was proposed, (3.10) holds true in
two extreme cases, namely when either only monomers exist or when all fractions are
concentrated in a single, large cluster and no smaller fractions are present. However,
one always has that M22  M1M3 by Holder's inequality. Thus, when substituting
(3.11) into (3.10), equality sign in the second equation for (3.10) has to be replaced
by  there. Therefore, the closed system
_M1 = kgF   krM1 (3.12)
_M2 = kgF + 4kp (M2 +M1)
2   kb

M22
M1
 M1

  krM2 (3.13)
is satised by solutions M1 to (3.12) and by subsolutions M2 to (3.13).
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3.3.2 Estimating brin clot formation
As it turns out, equations (3.12), and (3.13) can be explicitly solved under our current
assumption (3.3). Notice that using (3.1), (3.12) can be rewritten in the form
d
dt
 
ekrtM1

= kge
krtF =  ekrt _F
it then follows that
M1(t) = 0 for t < TM ; M1(TM ) = FM
 
1  e kgC  A (3.14)
M1(t) = Ae
 kr(t TM ) for t > TM (3.15)
Concerning the second moment, one also has that
M2(t) = 0 for t < TM ; M2(TM ) = A (3.16)
Notice that the values M1(TM ) = M2(TM ) = A are obtained from the fact that by
(3.1), (3.2) and (3.13) the jump of M1, M2 at t = TM is provided by instantaneous
activation of brinogen by thrombin at that time. We next point out that, on
multiplying both sides in (3.13) by e kr(t TM ) and upon noticing that e kr(t TM ) =
M1(t)
A for t > TM (cf. (3.15)) one readily sees that U(t) =
M2(t)
M1(t)
satises:
dU
dt
= 4kpAe
 kr(t TM )(U + 1)2   kb(U2   1) for t > TM (3.17)
U(TM ) = 1: (3.18)
Equation (3.17) is of Riccati type. Since U(t) =  1 is a particular solution, its
general solution can be sougth in the form
U(t) = Y (t)  1 (3.19)
To better understand the consequences of the various kinetic processes retained in
(3.17), the following situations will be separately considered:
1. Case: kp > 0, kb = kr = 0. When fragmentation and deactivation are
considered negligible with respect to coagulation, we obtain from (3.17) and
(3.19) that
U(t) =
1 + 8Akp(t  TM )
1  8Akp(t  TM ) (3.20)
which blows up at a time Tf given by
Tf = TM +
1
8Akp
(3.21)
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2. Case: kp > 0, kb > 0, kr = 0.
We now obtain from (3.17) and (3.19) that
U(t) =
kb + 4Akp
 
1  e 2kb(t TM )
kb   4Akp
 
1  e 2kb(t TM ) (3.22)
U(t) blows up at t = Tf if
1  e 2kb(Tf TM ) = kb
4Akp
(3.23)
which requires
kb < 4Akp (3.24)
Therefore, large fragmentation rates preclude the formation of brin clots.
When (3.23) holds, it follows from (3.23) that
Tf = TM   1
2kb
log

1  kb
4Akp

(3.25)
Note that (3.25) reduces to (3.21) in the limit kb ! 0. Moreover Tf (kb)
is increasing in kb, so that (3.21) provides a lower bound for (3.25) when
0 < kb  1.
3. Case: kp > 0, kb > 0, kr > 0.
When all kinetic rates are dierent from zero substitution of (3.19) into (3.17)
leads to
dY
dt
= f(t)Y 2 + 2kbY ; f(t) = 4kpAe
 kr(t TM )   kb (3.26)
so that Z =   1Y solves
dZ
dt
+ 2kbZ = f(t); Z(TM ) =  1
2
whence
Z(t) =e 2kb(t TM )

 1
2
+
Z t
TM
e2kb(s TM )f(s)ds

=
4Akp
2kb   kr

e kr(t TM )   e 2kb(t TM )

  1
2
(3.27)
for t > TM when 2kb 6= kr, and:
Z(t) = 4Akp(t  TM )e 2kb(t TM )   1
2
(3.28)
for t > TM and 2kb = kr. Assume now that 2kb > kr then, on setting:
Q =
4Akp
2kb   kr =
4FM (1  e kgC)kp
2kb   kr (3.29)
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it follows that U(t) = M2(t)M1(t) is given by:
U(t) =
1 +Q
 
e kr(t TM )   e 2kb(t TM )
1  2Q  e kr(t TM )   e 2kb(t TM ) (3.30)
Let g(t) = e kr(t TM )   e 2kb(t TM ) for t  TM . Clearly g(TM ) = 0, g(t) > 0
for t > TM and g(t) achieves a maximum at some time t = t
. A straightfor-
ward computation yields that:
t = TM +
1
2kb   kr log

2kb
kr

(3.31)
m = g(t) =

2kb
kr
  kr2kb kr   2kb
kr
  2kb2kb kr
(3.32)
Thus for U(t) in (3.30) to blow up at time Tf , we need
2Qm  1 (3.33)
where Q, m are respectively given in (3.29) and (3.32). If (3.33) holds, one
has that
Tf  TM + 1
2kb   kr log

2kb
kr

(3.34)
the case where 2kb < kr is similarly dealt with. Finally, when 2kb = kr blow
up for U(t) occurs if there exists Tf > TM such that
8Akp(Tf   TM )e 2kp(Tf TM ) = 1 (3.35)
It is readily seen that (3.35) holds if m = maxt>TM
 
(t  TM )e 2kb(T TM )

is such that 8Akpm
  1. Since m = (2ekb) 1 in this case, the resulting
condition reads:
4Akp > ekb (3.36)
We conclude this section by observing that our discussion can be extended to the
case where (3.3) is replaced by
(t) = C(x)(t  TM )
for some function C(x). One just has to replace C by C(x) in the corresponding
estimates, as for instance in (3.21). Note that this implies that Tf = Tf (x) so that
dierent clot nucleation centers may be generated at dierent times.
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3.3.3 Platelet activation and growth factor release
Besides cleaving brinogen, thrombin also mediates platelet activation [17]. Acti-
vation leads to platelets changing shape, sticking to each other and releasing the
content of their storage granules [7]. In the sequel we will denote by pa(t) the con-
centration of activated platelets at time t > 0. Ignoring deactivation eects, we
propose the dynamics of pa(t) to be given by:
_pa(t) = (P0   pa(t)) for t > 0 (3.37)
pa(0) = 0 (3.38)
Here  stands for thrombin concentration, P0 denotes the concentration of platelets
at t = 0 and  > 0 is an activation rate. Arguing as for (3.4) under assumption
(3.3), equations (3.37), (3.38) yield at once:
pa(t) =

0 if t < TM
P0(1  e C) if t > TM (3.39)
Upon activation, platelets are known to release a number of growth factors with
mitotic and chemotactic eects, including members of the VEGF, FGF, PADG,
and TGF families (cf. [1], [10], [13], [47]). We next describe the time and space
dynamics of one such factor g(x; t) irrespective of its specic biological function which
will be considered later on.
To that end we consider our fracture gap 
 = ( L2 ;
L
2 ) with L > 0 and assume
that g(x; t) is released by activated platelets in 
 and freely diuses within and
without 
. More precisely, we postulate that g satises:
@g
@t
 D@
2g
@x2
+ g = (t)pa(t)
 for  1 < x <1, t > 0 (3.40)
g(x; 0) = 0 for  1 < x <1 (3.41)
where 
(x) = 1 when x lies in 
, and 
(x) = 0 otherwise. Here D and  denote
respectively the diusion and half-life coecients of g(x; t). Concerning (t), we
assume it to be of the form:
(t) =

 > 0 for TM < t < T

0 otherwise
(3.42)
for some constant  and some T  > 0. The reason for that choice is that platelets
can only release such substances as they had initially stored, since they lack nuclei
and hence the possibility to synthesize new molecules.
The linear problem (3.40), (3.41) can be explicitly solved by classical methods to
give:
g(x; t) =
Z t
0
 Z L=2
 L=2
G(x  y; t  s)dy
!
e (t s)(s)pa(s)ds (3.43)
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where
G(x; t) =
e 
x2
4Dtp
4Dt
for  1 < x <1, t > 0. (3.44)
Recalling (3.39), for times TM < t < T
 (3.43) yields:
g (x; t) = P0
 
1  e C Z t
TM
 Z L=2
 L=2
G (x  y; t  s) dy
!
e (t s)ds (3.45)
whereas for t > T :
g (x; t) = P0
 
1  e C Z T
TM
 Z L=2
 L=2
G (x  y; t  s) dy
!
e (t s)ds (3.46)
3.3.4 Recruitment of mesenchymal cells (MSC). Formation of
early brin-collagen callus (EFC)
Having described the dynamics of a generic growth factor g (x; t) in our previous
Section, we now analyze the chemotactic eects induced by growth factors in the
population of MSCs and their impact on remodelling the brin net to produce a rst
brin-collagen template. We assume that a baseline population of MSC is located at
the periosteum, near the fracture border and that when stimulated by g (x; t) such
population moves inwards into the fracture gap. When doing so, MSCs eventually
become precursors of various cell types instrumental to achieve bone repair. More
precisely, let us denote by m (x; t) the concentration of MSCs at a point x at a time
t. We postulate that m satises:
@m
@t
+
@
@x

m
@g
@x

= 0 ;  1 < x <1; t > TM (3.47)
m (x; TM ) = 0 for   L
2
 x  L
2
; (3.48)
m (x; TM ) = m0 for x   L
2
; x  L
2
: (3.49)
where  > 0 is a chemotactic coecient andm0 is the concentration of MSC available
at the periosteum reservoir. Notice that both diusive and mitotic eects have been
ignored in (3.47). Using (3.45), (3.46) an explicit formula can be obtained for @g@x .
To this end, we note that on setting:
erf(u) =
2p

Z u
0
e x
2
dx (3.50)
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one has that
I (x; t) =
Z L=2
 L=2
e 
(x y)2
4Dtp
4Dt
dy
=
1
2
 
erf
 r
Tc
t
(1=2 + x=L)
!
+ erf
 r
Tc
t
(1=2  x=L)
!!
(3.51)
where
Tc =
L2
4D
: (3.52)
Then there holds:
@I
@x
(x; t) =
1p

r
Tc
t
1
L

e 
Tc
t (1=2+x=L)
2   e Tct (1=2 x=L)2

:
Setting P^0 = P0
 
1  e C it follows that for TM < t < T :
@g
@x
(x; t) = P^0
Z t
TM
@I
@x
(x; t  s) e (t s)ds
=
P^0p
L
Z t
TM
r
Tc
t  s

e 
Tc
4(t s) (1+2x=L)
2   e  Tc4(t s) (1 2x=L)2

e (t s)ds : (3.53)
At this juncture it is convenient to make use of non-dimensional variables given by:
u =
2x
L
;  =
t  s
Tc
; t =
t  TM
Tc
(3.54)
Upon introducing (3.54) for times t such that 0 < t < T
 TM
Tc
(3.53) can be recast
in the form:
@g
@x
(u; t) =
P^0Tcp
L
Z t
0

e
 

1+u
2
p

2
  e 

1 u
2
p

2 e Tcp

d (3.55)
When t 1 so is  , and the integrand in (3.55) is almost zero except for values close
to interval boundaries u = 1. For instance, when t = 0:01 a plot for @g@x (u; t) is
provided in gure 3.6 below.
When t = O (1), that is for times t such that t TM = O (Tc), the prole for @g@x (u; t)
looks as depicted in Figure 3.7. Such a prole is mantained until it begins to decrease
for t > T . Therefore the main contributions to @g@x are achieved for TM < t < T
,
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Figure 3.6: The form of @g@x for
t = 0:01. All parameters involved are set equal to
one for convenience.
Figure 3.7: A plot of @g@x for
t = 1. All parameters involved are set equal to one for
convenience.
Figure 3.8: A plot of @g@x ( 1; t) as a function of t, showing quick stabilization to a
plateau-like prole. Parameter values as in Figures 3.6 and 3.7.
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and are provided by values of u near to the boundary values u = 1. For instance,
on writing:
@g
@x
( 1; t) = P^0Tcp
L
Z t
0

1  exp

 1


e Tcp

d (3.56)
one may obtain a plot for @g@x ( 1; t) as a function of t that looks as in Figure 3.8:
Note that @g@x ( 1; t) quickly saturates to a constant value. Actually, one has that:Z t
0

1  e  1
 e Tcp

d  1p
Tc
Z 1
0

1  e Tcv
 e vp
v
dv
 1p
Tc
Z 1
0
e vp
v
dv =
r

Tc
Hence:

@g
@x
( 1; t)  P^0
p
Tc=
L
 a ; (3.57)
and a similar result can be derived at u = 1. We are now ready to estimate the time
it takes for a front of MSCs to reach the center of the gap at x = 0. Once front x (t)
has entered into a linear regime (which in particular occurs for times t  TM  3Tc;
see Figure 3.8), its equation reads:
dx
dt
= 
@g
@x
(3.58)
x (TM ) =  L=2
Since @g@x   au =  2axL for 0 < t < T
 TM
Tc
and  L2 < x < 0, (cf. 3.57) we actually
obtain that the dierential equation in (3.58) can be approximated by:
dx
dt
=  2a
L
x (3.59)
whence
x (t) =  L
2
e (
2a
L (t TM )) (3.60)
On its turn, the concentration of MSC can be estimated from (3.59) and (3.47),
which together yield:
@m
@t
  2ax
L
@m
@x
=
2a
L
m (3.61)
Thus, if x (t) denotes the characteristic curve of (3.61) starting from x0   L2 , we
obtain from (3.61) that:
m (x (t) ; t) = m0e
2a
L (t TM ) (3.62)
whereas m (x (t) ; t) = 0 if x0 >  L2 . We may now estimate the time TF of formation
of EFC as follows. Due to the approximations made to derive (3.60) the function
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x(t) dened there will never reach x = 0 in a nite time. We will thus say that EFC
has been formed when x(t) reaches instead a value  " with 0 < "  1 arbitrarily
selected. We then may compute TF from the relation:
 L
2
e 
2a
L (TF TM ) =  "
which gives at once:
TF = TM +
p
DL
P^0
log

L
2"

; (3.63)
provided that T  > TF (see (3.55)).
We conclude this section by remarking about the negligible impact of diusion
in the process under consideration. To avoid technicalities, we just show here that
adding diusion in (3.47) results in a small correction in the inward motion of MSC
front. More precisely, let us replace (3.47) by
@m
@t
+
@
@x

m
@g
@x
 Dm @m
@x

= 0 ;  1 < x <1 ; t > TM (3.64)
where Dm > 0 with initial conditions (3.48) (3.49). Using again the approximation
@g
@x    2aL x in (3.64) the resulting equation can be written in the form
@m
@t
  2ax
L
@m
@x
  2a
L
m Dm @
2m
@x2
= 0 (3.65)
We rst estimate the characteristic time  tr needed to travel a distance
L
2 under
transport eects. The time to ll an innitesimal interval of the form [x  dx; x] is
given by:
dx
 2ax=L = dt :
Integrating this expression between L=2 and a characteristic size epsilon () (which
can be interpreted as an intercellular space) we nd that  tr satises the following
relationship: Z tr
0
dt =
Z L
2

L
2ax
dx
and then, we have that:
 tr =
L
2a
log

L
2

Analogously, we estimate the characteristic time di for the gap lling due to a
diusion process:
di 
 
L
2   
2
Dm
Comparing both values of characteristic times we obtain:
 tr
di
=
LDm
2a
log
 
L
2
 
L
2   
2  LDm2a log
 
L
2
 
L
2
2 = 2DmaL log

L
2

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Assuming a value of  of L100 , then we can estimate the quotient (let us recall that
L = 2 mm):
 tr
di
=
2Dm
aL
log

L
2

=
2  10 6
0:5  10 2  1:25  0:2 log(50)  6  10
 3
which conrms the low impact of diusion in the process under consideration, show-
ing that the transport eects occur in a much shorter characteristic time than diu-
sive ones.
3.4 A sequence of times
We now briey discuss on the comparative values of the characteristic times obtained
in our previous sections. To begin with, we observe that a correct timing of the overall
process requires that
TM < Tf < Tc < TF < T
 (3.66)
where TM , Tf , Tc, TF , and T
 have been respectively dened in (3.3), (3.21), (3.52),
(3.63) and (3.42). For simplicity, we take TM = 0 in the sequel, since hematoma
formation is known to begin shortly after fracture. On the other extreme, it is
reasonable to select T  of the order of the average platelet life-span, so that we may
take:
T   10 days (3.67)
(cf. [33]). To estimate the values of the remaining times in (3.66) is in principle
feasible by means of the corresponding formulas obtained. However, while some of
the parameters appearing there can be reasonably guessed (at least from in vitro
experiments), little can be said about parameters as  and  appearing in (3.37)
and (3.40) respectively. We next describe the type of information on the sequence
of times in (3.66) that can be obtained under current uncertainty constraints.
To begin with, consider the value obtained in (3.21) for Tf . In the earliest de-
tectable stages in brin clot formation, when fragmentation and deactivation eects
are ignored, the value of Tf can be compared with the prothrombin time Tp, a pa-
rameter routinely measured in blood tests [4]. Tp is measured in decalcied plasma
where platelets have been removed, and a typical value obtained is Tp  10 seconds.
If we compare the fastest estimate for Tf obtained in Section 3.2 (see (3.21)), we
should have:
Tf =
1
8FMkp (1  e kgC)  10 sec (3.68)
FM in (3.68) is commonly estimated in blood tests. A typical value for FM is
FM  3 gr/l = 9000 nM (3.69)
(see [26]). Fibrin polymerization rates seem to have been reported only in vitro ([26]
and references therein). For instance, we may take
kp = 4 10 3 (nM min) 1 (3.70)
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(cf. [58]). One then readily sees that 8FMkp  4:8 (sec) 1. Then estimate (3.68)
follows provided that
1  e kgC = 1
48
(3.71)
which holds provided that kgC  0; 0211. As a matter of fact, values for kg have
been reported ([58], [26]). For instance, it has been suggested that
kg = 3 10 4 (nM min) 1 (3.72)
(cf. [58]). From (3.71) and (3.72) we obtain that under such assumptions
C  10
4
3
0:0211 nM min = 0:47FM sec  FM
2
sec : (3.73)
It has to be stressed that, as remarked in Section 2, the time to develop a mature
brin clot is considerably larger than the value provided in (3.68). Indeed, to keep
track of the actual unfolding of a brin net, quantities other than the prothrombin
time are measured in clinical practice [46]. Examples are the clotting time, CT,
dened as the time required for blood to form a initial clot from a given volume
of blood in a glass tube, which usually ranges between 5 to 15 minutes, and the
retraction time RT, dened as the time taken for a blood sample to become solid
enough so that it could separate from the walls of a crystal vessel where coagulation
is taking place, and that ranges between 1 to 2 hours. As a matter of fact, times as
those reported for CT or RT can be obtained from our formulas (3.21) or (3.25) by
selecting C and kb in a a suitable manner there.
Consider now Tc given in (3.52) through the relation
Tc =
L2
4D
(3.74)
where D is the diusion coecient of the growth factor considered. Since not much
seems to be known about in vivo values for D, we may now try on (3.74) a typical
diusivity value, say D = 10 6 cm2=sec. Taking now L = 2 mm (see Appendix A)
we obtain:
Tc = 10
4 sec  3 hours (3.75)
Notice that by (3.68) and (3.75), Tf  Tc. Moreover, a slower diusivity will result
in an increased value of Tc according to (3.74).
Let us now remark on TF , the time required for early callus formation, for which
we have obtained estimate (3.63) in Section 3.4. For deniteness, let us take " = e
 N
2
for some integer N there. Or taking N such that N  log(L), we see that
TF 
p
DLN
P0 (1  e C) (3.76)
Some of the parameters in (3.76) are known within reasonable ranges. For instance,
values for half-lives of growth factors have been reported in the literature, although
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they considerably dier from one reference to another. For deniteness we take here
 = 6  10 4 (min) 1 [3]. Keeping to our previous choices L = 2 mm and D = 10 6
cm2=sec, and selecting N = 50p
6
we deduce that
p
DLN  10 4 cm2=sec. Platelet
counts are commonly made in blood tests, with values ranging between 1:5  105 to
40  105 units per cubic millimeter, and mean platelet weight has been estimated to
be about 10 picograms [34]. We therefore may take P0 = 2gr=liter as a reference
value. On the other hand, the chemotactic coecient  has been measured for
neutrophils in some experimental settings [56] where values as 400 cm2=(M  sec)
have been reported. Just for comparison purposes, we may consider here growth
factor concentrations in the previous estimate for  so that P0 = 10
 5 cm2=sec. In
this manner we will obtain: p
DLN
P0
' 10 (3.77)
Concerning the remaining parameters in (3.76) it is natural to assume  = O
 
1
T

where T  is given in (3.67). On taking  = 1T and selecting then the conversion
factor 1  e C ' 150 , we would eventually arrive at
TF ' T

5
' 2 days (3.78)
Needless to say, our previous estimates have to be considered as very preliminary.
For instance, for times of the order of CT or RT, additional characteristic times of
the various coagulation and brinolytic networks involved need to be investigated.
Actually, CT is used as part of hemophilic test, so that the dynamics of individual
coagulation factors as FVIII need to be accounted for there. On the other hand, once
the brin clot has been formed (which begins to occur quite fast; see [5]) the half life
of growth factors can be extended due to their anchorage in such a net ([49], [60]).
Actually, (3.76) suggests that an increase in that value from  to 4 would result in
doubling the corresponding value in (3.76). This eect, however, can be somehow
compensated by the slowdown in diusivity D as the medium becomes denser.
3.5 Concluding remarks
In this work we have used mathematical models to explore the early stages of bone
fracture repair. Bone health is essential to ensure high quality of human life, and
its signicance becomes even more important in aging societies, as many developed
countries are. Human bone has an impressive capability for self-repair. In fact,
human skeleton is constantly being remodelled, and as we have already noticed at
the Introduction, bone microfractures induced by exercise are routinely self-healed
without being ever noticed [6]. It has been observed that such repairing mechanisms
repeat many processes present at the developmental program that drives ossication
during the embryonic stage [18], [19]. Moreover, bone repair has some common
features with other tissue repairing processes as wound healing [32], [52]. It follows
from these remarks that each improvement in our understanding of the process of
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bone self-repair may have signicant consequences, and it is widely expected that
quantitative models of bone healing may provide valid contributions to that end.
However, as in many other biological processes, when faced with the goal of pro-
viding mathematical models for bone repair, one has to confront a signicant obsta-
cle. More precisely, while many of the key agents in the process under consideration
have been identied, little is known concerning the precise manner whereby these
agents coordinate themselves to achieve bone repair. For instance, only partial infor-
mation seems to be available on the detailed network hierarchy of the corresponding
biochemical cascades, and precise information on the order and rate constants of
the chemical reactions involved in cell signalling during that process remain largely
unknown. This leaves few options except selecting ad hoc such parameters when it
comes to carry out simulations to recover observed behaviours. However, it is well
known that a given dynamics can be recovered from dierent sets of parameter val-
ues, so that the insight gained through extensive parameter tting has to be carefully
weighted ([29], [22]).
Bearing these remarks in mind, we have aimed in this work at discussing simple
models that could however provide some information into the specic issue addressed,
namely the timing of events taking place at the early stages of bone fracture repair.
Specically, we restrain our attention to processes unfolding from bone break up
until the formation of a rst brous callus that, upon suitable remodelling , will
lead to successful bone repair. While comparatively simple when compared with
later stages (for instance, mechanical eects do not play yet so relevant a role as in
posterior bone remodelling ) , we already deal here with some of the main processes
that will be at work later on, as chemotactic recruitment of MSCs (mesenchymal
stem cells). MSCs will thus divide and dierentiate to produce cell lineages whose
interaction with previous elastic scaolds will eventually lead to complete fracture
healing. Actually , the formation of the rst (and crucial) such scaold (a brin net)
is addressed in detail here , and its onset is kept track of and characterized as the
unfolding of a sol-gel phase transition.
Concerning the simplicity of our models, a few words are in order. When dealing
with any of the processes considered, we have attempted to focus on the main fea-
tures needed to derive the sought-for information, namely the time it takes for such
a process to develop. When doing so, we have considered eective processes, where
in particular various biochemical cascades have been lumped into a single equation,
rather than exploring the intricacies of each aspect involved. Our approach is illus-
trated by our discussion on thrombin-induced brin polymerization in Section 3.1,
where further remarks on the issues addressed can be found.
As a consequence of our work, some estimates for what we retain to be the main
characteristic times of the earliest stages considered have been obtained. These have
been summarized and estimated in Section 3 and 4 following a brief survey on the
main underlying biological aspects which makes the content of Section 2 . We have
discussed in section 4 how meaningful estimates for such characteristic times can be
provided, even in the presence of large parameter uncertainty, when our model is
compared with experimental data. However, additional work is required to improve
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the form of the estimates therein derived. Particularly, we have selected for that
purpose the induction of thin fractures in rats, for which a number of experiments
have been performed (for the corresponding experimental set up, see Appendix A).
Finally, while keeping models as simple as possible , we have succinctly discussed
on a number of possible extensions of the results obtained, as for instance the case
where thrombin sources are spatially distributed in Section 3.1, or a justication
of the negligible nature of diusion aspects in the chemotactic recruitment of MSCs
during early callus formation in Section 3.4. Other aspects, however, will require of a
more detailed analysis. A particularly relevant example of the latter is the evaluation
of the robustness and redundancy properties induced by the simultaneous action of
several growth factors whith partially overlapping functions. We intend to address
this and other related issues in future work.
Universidad Complutense de Madrid
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AppendixA
Details of computer simulations of
the model of BMU operation during
bone remodeling
A.1 Time evolution of the BMU
 Initialization: Simulations take place in a two-dimensional cellular automata
(CA) of 150 x 250 boxes. 125 rows of this matrix are initially occupied by bone
matrix and the rest by bone marrow. A row of OBL lies in the interface between
them. OCYs are initially located at xed, regularly spaced positions within
the bone matrix. A random perturbation is then applied to their positions
to avoid any potential eect of symmetries on the simulations of the model.
At this point, OCYs and OBLs release signals that diuse through the bone
matrix until an equilibrium is attained. This equilibrium is determined by the
balance between signal production and decay. In this moment, a region of OCY
apoptosis is randomly dened within a priori dened boundaries (Depth :=
maximum depth and Width := maximum width).
 Time evolution:
Simulations of the model occur in discrete time steps of length t = 0:01. The
input for an iteration of the model corresponding to time t = t0 includes a set
of vectors (one for each of the cells coexisting in the model at that time) with
the coordinates of the box occupied by the cell, and its state variables (amount
of inhibitory molecules).
1.- OBL
The state variable considered in the model for the i-th OBL is the amount of
activation inhibitor dBi . The corresponding vector is:
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vBi(t0) = f(x; y); dBi(t0)g
2.- OBA
For each OBA there are three dierent inhibitory molecules, namely cA, dA
and aA, blocking cell division, dierentiation and apoptosis. The state vector
for the i-th OBA is:
vAi(t0) = f(x; y); fcAi(t0); dAi(t0); aAi(t0gg
3.- OPL
Dierentiation of OPL into OCL is controlled by the inhibitor dP , so that the
state vector of the i-th OCP is given by:
vPi(t0) = f(x; y); dPi(t0)g
4.- OCL
Active osteoclast can die by apoptosis and dig into old bone. The state vector
for the i-th OCL includes the amount of apoptosis inhibitor aCi and the amount
of old bone bCi at the box occupied by the OCL:
vCi = f(x; y); faCi(t0); bCi(t0)gg
Input also includes the values of signals S, T and R at each box of the CA.
The rst step of each iteration consists in the denition of a system of ordinary
dierential equations that describe the dynamics of the state variables (see
Section 2). It consists of NB(t0)+3NA(t0)+NP (t0)+2NC(t0) equations,
where NB, NA, NP and NC are the number of OBL, OBA, OCP and OCL at
time t0 respectively. The system is then solved numerically using the explicit
Runge-Kutta method implemented in the function NDSolve of Mathematica
(Wolfram Research, Inc., Mathematica, Version 9.0, Champaign, IL).
If neither the amount of bone at a box occupied by a OCL or some of the
inhibitors goes to zero during a time step the state of signals S, R and T
is actualized and the model moves to the next time step. Alternatively, the
model displays dierent behaviors depending on what variable (or variables)
have gone to zero:
1.- OBLs activation inhibitor (dB)
This corresponds to the activation of one or more OBLs. In this case, the acti-
vated OBL are removed from the list of cells of the model, and their positions
in the CA are occupied by newly formed OBAs.
2.- OBAs division inhibitor (cA)
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OBAs form a continuous layer of cells that progresses into the cutting cone
created by OCL. By construction, only OBAs that are not located in boxed
adjacent to bone can divide. Moreover, OBA division can only occur if some of
the OBA are not attached to bone yet. In case of OBA division, the position
of OBAs is recalculated as summarized in Figure A1.
Figure A.1: Movement of OBAs after cell division. A) The layer of OBAs (in
orange) is adjacent to old bone (in grey). There are 7 available positions for new
OBAs marked with a thick black line. B) OBAs attached to the bone surface (in
red) can neither divide nor move. C) In case of cell division, one new OBA appears.
In the case depicted in the gure there are 6 OBAs after cell division that can move,
and 7 free positions, so the layer of OBAs cannot progress into the resorpted bone.
The new OBA is located in a cell adjacent to that of the dividing OBA. D) After a
new cell division there are 7 OBA free to move, so the front of OBA can occupy the
next set of available positions as shown in E. E) OBAs that reach a position adjacent
to bone (OBAs labelled with 1 and 7 in red) remain xed and do not divide. F)
When all OBAs are attached to the bone surface cell division is no longer possible.
From this moment, OBAs start to secrete osteoid matrix, can undergo apoptosis and
move downwards.
3.- OBAs apoptosis and dierentiation inhibitors (aA and dA)
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During the bone formation stage, OBAs form a continuous layer of cells that
lls the cutting cone created by OCL with new osteoid matrix. Apoptosis of
OBAs and dierentiation into OCY entail the movement of the OBA layer into
the empty cutting cone as described in Figure A.2. In case of dierentiation,
the OBA is replaced by a new OCY in the same box.
Figure A.2: Movement of OBAs after apoptosis and dierentiation. A) A
layer of 15 OBAs (in red) is adjacent to the bone matrix. There are 12 available
positions for the new layer of OBAs, marked with a thick black line. New positions
are bounded by the layers of OBAs and OBLs. B) In this moment, the number
of apoptotic (8 and 12, in orange) and dierentiated (4, in blue) OBAs equals the
dierence between the current number of OBAs (15) and the number of available
positions (12), so that the layer of OBAs can move. C) Boxes that were occupied
by OBAs in the previous stage are now lled with osteoid (yellow). A new OCY is
placed in the box where an OBA has dierentiated.
4.- OCPs dierentiation inhibitor (dP )
OCPs are located adjacent to the layer of OBLs. In case of activation, the
corresponding OCP is replaced by a newly formed OCL that moves to the
closed box within the bone matrix that is not occupied by any other cell.
5.- OCLs apoptosis inhibitor (aC)
OCLs whose apoptosis inhibitor disappears are removed from the set of cells
in the model for the next iteration.
6.- Bone removal by OCPs (bP )
OCLs remove old bone from the box where they are located according to
equation []. When the amount of bone goes to zero, the OCL moves to one of
the unoccupied adjacent boxes in the bone matrix. The OCL choses the box
with the highest amount of S signal that is farther from the OBL layer.
After cell fate choices, the set of cells and the amounts of signals S, T and R
are updated and the model starts a new iteration.
 End of the simulation:
Simulations end when the bone remodeling process is completed (old bone has
been replaced by new osteoid matrix) and a new equilibrium (for signals S and
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T ) has been reached.
A.1.1 Pseudo-code guidelines
Input parameters
tmax := maximum duration of simulations
Depth := maximum depth of the apoptosis region
Width := maximum width of the apoptosis area
bone(x; y) := 1 if the box is occupied by bone at initial time and 0 other-
wise
position(OCY; 0) := initial position of OCYs
position(OBL; 0) := initial position of OBLs
position(OCP; 0) := initial position of OCPs
Structural parameters
hk := eect of external signals of type h on the dynamics of inhibitors in
cells of type k
DB := maximum amount of inhibitor dB that can accumulate inside a
OBL
dph(d) := diusion prole of signal h as a function of distance d
h := rate of decay of signal of type h
Variable parameters
fak0; dk0; ck0g := amount of inhibitors in newly formed cells of type k
A Distance of OCY inhibition of OBA dierentiation
Qhk := rate of production of signal of type h by cells of type k
Initialization
1 Input the bone matrix bone(x; y)
3 Input and the boxes occupied by OCY, OBL and OCL.
4 Diusion and decay of signals S and T until equilibrium
5 Dene a random region of OCY apoptosis
6 Set t := 0
7 REPEAT
8 Input the set of positions and state variables of all cells
9 Input the amount of signals S, T and R at each box of the CA
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10 Write the system of ODEs that describe the dynamics of the state
variables as functions of the external signals
11 REPEAT
12 Numerical integration of the systems of ODEs for a time step t
13 Diusion and decay of signals S, T and R during the time step
t
14 set t = t+t
15 UNTIL some state variable goes to zero
16 If (dBi(x; y; t)  0) then remove the i-th OBL and add a new OBA
at box (x; y)
17 If (cAi(x; y; t)  0) then
18 add a new OBA at a box adjacent to (x; y)
19 recalculate OBAs positions
20 If (aAi(x; y; t)  0) then
21 remove the i-th OBA
22 recalculate OBAs positions
23 If (change in OBAs position) then ll old positions with osteoid
24 If (dAi(x; y; t)  0) then
25 remove the i-th OBA
26 add a new OCY at (x; y)
27 recalculate OBAs positions
28 If (change in OBAs position) then ll old positions with osteoid
30 If dPi(x; y; t)  0 then
31 remove the i-th OCP
32 add a new OCL at the box of the bone matrix closest to (x; y)
33 If aCi(x; y; t)  0 then remove the i-th OCL
34 If bBi(x; y; t)  0 then
35 set bone(x; y) = 0
36 move the OCL to a new position in the bone matrix
# We remark that several cell decisions can take place simultaneously
37 UNTIL the end of bone remodeling process
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Parameter Description Value
(Depth;Width)
Maximum depth and widht of the
OCY apoptosis region
(80, 80)
dB0
Initial amount of dierentiation
inhibitor in newly formed OBLs
3
DB
Maximum amount of dierentiation
inhibitor in OBLs
4
(S1B ; 
S1
B )
OBL
structural parameters
(1, 1)
(cA0; aA0; dA0)
Initial amount of inhibitors in
newly formed OBA
(1.5, 5, 2)
(TA; 
S1
A ; 
S2
A ; 
S3
A ; 
S4
A )
OBA
structural parameters
(0.01, 0.6, 15, 1)
A
Radio of OCY ihibition
of OBA dierentiation
1
dP0
Initial amount of dierentiation
inhibitor in OCP
0.5
(RP ; 
S
P )
OCP
structural parameters
(3, 5)
aC0
Initial amount of apoptosis
inhibitor in OCL
1
(S1C ; 
S2
C ; 
S3
C ; 
S4
C )
OCL
structural parameters
(2, 2.5, 2, 6)
(dpS(d); dpT (d); dpR(d)
Diusion prole of
signals S, T and R
dpS(d) = dpT (d) =
= dpR(d) =Max(0; 4  d)
(S ; T ; R)
Decay rates of
signals S, T and R
(0.01, 0.01, 0.01)
(QSY ; Q
T
Y )
Rates of production of
signals S and T by OCYs
(10, 1)
QTB
Rate of production of
signal T by OBL
2
(QTA; Q
R
A)
Rates of production of
signals T and R by OBAs
(1, 15)
Table A.1: Parameters
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Figure A.3: Flowchart of the proposed model of BMU software as described
in the Appendix.
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Experimental procedure
Sixteen 10-week-old male Sprague-Dawley rats were obtained from the animal fa-
cility building of the University of Oviedo. Bone fractures with 2:5 mm average
width were produced by the manual breakage using plate-bending devices, placed
at the distal 3 third of the right tibia. The animal study protocol was approved
by the local committee and conformed to Spanish animal protection laws. Rats
were anesthetized and sacriced by cervical dislocation 3, 6, 12 and 24 hours af-
ter fracture (n=5). Tibiae were isolated and cut through the sagittal plane of the
metaphyseal fracture region into two equal sized parts and xed by immersion in 4%
paraformaldehyde at 4 Co for 12 h, rinsed in PBS, decalcied in 10% EDTA (pH 7.0)
for 48 hours at 4 Co, dehydrated through a graded ethanol series, cleared in xylene
and embedded in paran. Sections were serially cut at a thickness of 5 m, mounted
on Superfrost Plus slides (Menzel-Glaser), stained with a trichromic method using
Weigert?s hematoxylin/alcian blue/picrofuchsin and viewed and photographed on a
Nikon Eclipse E400 microscope.
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